Patient 1 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 1; age: 55.6; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -4.08; death due to tumor: 0; survival time (month): 41.92
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325238
sample_title: Patient 1 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 1; age: 55.6; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -4.08; death due to tumor: 0; survival time (month): 41.92
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 29d1ded0df7d1786fd08a742a607037f796c4cee537559621d8620e0b49159da
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 2 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 2; age: 65.6; gender: M; tissue: rectal tumor; kras mutation: I21L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.27; death due to tumor: 0; survival time (month): 40.27
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325239
sample_title: Patient 2 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 2; age: 65.6; gender: M; tissue: rectal tumor; kras mutation: I21L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.27; death due to tumor: 0; survival time (month): 40.27
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9d3f528849310ec3f1b03c27d64d02ee805658c506089416a009654ab2d961b4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 3 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 3; age: 62.7; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.62; death due to tumor: 0; survival time (month): 29.62
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325240
sample_title: Patient 3 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 3; age: 62.7; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.62; death due to tumor: 0; survival time (month): 29.62
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 969fe5647998aaf3320d5df79f8b22a704a29b48763cd6d0962f38f000971272
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 4 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 4; age: 61.8; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.65; death due to tumor: 0; survival time (month): 32.65
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325241
sample_title: Patient 4 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 4; age: 61.8; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.65; death due to tumor: 0; survival time (month): 32.65
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9fa64121dccf7ed00c406908dc521b06919d3ca4768e9fc0a7199863e54b538a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 5 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 5; age: 52.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 31.59; death due to tumor: 0; survival time (month): 31.59
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325242
sample_title: Patient 5 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 5; age: 52.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 31.59; death due to tumor: 0; survival time (month): 31.59
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e094a385319d0d299c8e9486621880d7592efca5b39332f1d7810eda10f4fe68
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 6 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 6; age: 59.1; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.52; death due to tumor: 0; survival time (month): 34.52
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325243
sample_title: Patient 6 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 6; age: 59.1; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.52; death due to tumor: 0; survival time (month): 34.52
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cbc740535edf57adb7eba038d09120c36a803e17a732ea279db776af1855dbea
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 7 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 7; age: 70.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.68; death due to tumor: 0; survival time (month): 32.68
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325244
sample_title: Patient 7 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 7; age: 70.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.68; death due to tumor: 0; survival time (month): 32.68
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9a763a92d1b21959480785223d814120f760772c5d3834b52ee5e4980af5d8ef
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 8 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 8; age: 60.7; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 30.31; death due to tumor: 0; survival time (month): 30.31
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325245
sample_title: Patient 8 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 8; age: 60.7; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 30.31; death due to tumor: 0; survival time (month): 30.31
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: c07fa13ba4b78e58190bb9ba824665308aa6ef38d5a178cf2eebfabaa1e1fce9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 9 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 9; age: 55; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 28.08; death due to tumor: 0; survival time (month): 28.08
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325246
sample_title: Patient 9 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 9; age: 55; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 28.08; death due to tumor: 0; survival time (month): 28.08
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 068449f389d4244136d2b5727d121fe1b1166ddd6cef7b6a8cb4441d61153ea3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 10 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 10; age: 53.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 27.55; death due to tumor: 0; survival time (month): 27.55
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325247
sample_title: Patient 10 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 10; age: 53.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 27.55; death due to tumor: 0; survival time (month): 27.55
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d12256d63a137a9e3a743bd2aebc316d6a6911bb9c3d99168f03f15e12d1e547
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 11 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 11; age: NA; gender: M; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: NA; metastasis after rct: NA; cancer recurrance after surgery: 0; disease free time (month): NA; death due to tumor: 0; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325248
sample_title: Patient 11 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 11; age: NA; gender: M; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: NA; metastasis after rct: NA; cancer recurrance after surgery: 0; disease free time (month): NA; death due to tumor: 0; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ffc7992a3823670f72c9bf867d7a589f41717c1fa34f64e22c1963ffb4dd1774
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 12 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 12; age: 58.6; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 14.93; death due to tumor: 0; survival time (month): 14.93
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325249
sample_title: Patient 12 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 12; age: 58.6; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 14.93; death due to tumor: 0; survival time (month): 14.93
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f7195f93e918b1e8c9e1960d716bf450061804d5887fd8578212ff5ac8389348
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 13 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 13; age: 68.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.38; death due to tumor: 0; survival time (month): 23.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325250
sample_title: Patient 13 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 13; age: 68.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.38; death due to tumor: 0; survival time (month): 23.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7c372725f508a52004fb1ebda55daf6e525bb7ac84d4c7f2bd0e8c445190d1c9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 14 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 14; age: 58.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 6.71; death due to tumor: 0; survival time (month): 25.81
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325251
sample_title: Patient 14 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 14; age: 58.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 6.71; death due to tumor: 0; survival time (month): 25.81
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4b5506a2bfe1b9f06c5211875bb1b431d08fce3ebb1b83d9db022f8694ce3771
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 15 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 15; age: 70.1; gender: M; tissue: rectal tumor; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: NA; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325252
sample_title: Patient 15 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 15; age: 70.1; gender: M; tissue: rectal tumor; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: NA; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 40eac4b38ba5a4380829249330fe82cd091722177cf8c0abf14c643189cf9cea
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 16 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 16; age: 77.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.72; death due to tumor: 0; survival time (month): 34.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325253
sample_title: Patient 16 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 16; age: 77.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.72; death due to tumor: 0; survival time (month): 34.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f5ec3265aa8757d77c2425637ede80d76373dba5db2fdb24d994a5c8b1bc0308
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 17 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 17; age: 68.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.63; death due to tumor: 0; survival time (month): 18.28
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325254
sample_title: Patient 17 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 17; age: 68.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.63; death due to tumor: 0; survival time (month): 18.28
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 53cf068d3f7445a2db7ce40147f171d3a5b6e99df295ce9f347333405cfc11ad
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 18 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 18; age: 75.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.32; death due to tumor: 1; survival time (month): 10.26
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325255
sample_title: Patient 18 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 18; age: 75.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.32; death due to tumor: 1; survival time (month): 10.26
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 59cb443d30ef5b08720ca85cb6f66f415f2315753b44f003e6bbc6c4db552d50
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 19 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 19; age: 76.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 10.62; death due to tumor: 0; survival time (month): 10.62
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325256
sample_title: Patient 19 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 19; age: 76.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 10.62; death due to tumor: 0; survival time (month): 10.62
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1e90f12185b7985e03acd9217191bb32b4ad5765854ad723217eb84fd5cc4fc9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 20 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 20; age: 38.2; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.25; death due to tumor: 0; survival time (month): 8.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325257
sample_title: Patient 20 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 20; age: 38.2; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.25; death due to tumor: 0; survival time (month): 8.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e0ab85b5035bf18237958c45e7f7cfbbbdea3790e6dd2d91cd4601d3aad0296b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 21 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 21; age: 61.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -0.62; death due to tumor: 1; survival time (month): 5.75
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325258
sample_title: Patient 21 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 21; age: 61.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -0.62; death due to tumor: 1; survival time (month): 5.75
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2098dfec1e6cd67a0a70968b0bbb45f37df9c5eeaaf3c5983d1e8d0767f239ea
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 22 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 22; age: 69.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.28; death due to tumor: 0; survival time (month): 23.28
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325259
sample_title: Patient 22 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 22; age: 69.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.28; death due to tumor: 0; survival time (month): 23.28
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 816cdd18c2bfccf5a701ba91bfae140e74d09c92b96c615fe4d8063a7ea02f9d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 23 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 23; age: 54.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.8; death due to tumor: 0; survival time (month): 23.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325260
sample_title: Patient 23 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 23; age: 54.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.8; death due to tumor: 0; survival time (month): 23.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 11efcaf877fc67b1f5bf032534c9002f40ae63c7c644380387cd09fe7fffb901
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 24 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 24; age: 57.4; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.33; death due to tumor: 0; survival time (month): 7.33
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325261
sample_title: Patient 24 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 24; age: 57.4; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.33; death due to tumor: 0; survival time (month): 7.33
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 68c00a605a3eefeaa66693ddc80f8018ab472dc3d59d9c0fc9cf806572f90101
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 25 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 25; age: 61.3; gender: M; tissue: rectal tumor; kras mutation: Q61P; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 15.25; death due to tumor: 0; survival time (month): 24.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325262
sample_title: Patient 25 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 25; age: 61.3; gender: M; tissue: rectal tumor; kras mutation: Q61P; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 15.25; death due to tumor: 0; survival time (month): 24.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 73b0961c0b085be01cdb4d88265693720b6ff17f71a2b9984db9fa0c4a83fcc3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 26 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 26; age: 47; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.55; death due to tumor: 0; survival time (month): 22.55
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325263
sample_title: Patient 26 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 26; age: 47; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.55; death due to tumor: 0; survival time (month): 22.55
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f94d277a80cebf4c4571b08b2d104975bad08820ac9187465c0df81a9e574635
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 27 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 27; age: 62.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.22; death due to tumor: 0; survival time (month): 22.22
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325264
sample_title: Patient 27 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 27; age: 62.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.22; death due to tumor: 0; survival time (month): 22.22
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ffd029da5eb53db8e39a15bc6624c79bddb307f5a84651bd18a953ef0843914f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 28 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 28; age: 51.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 17.98; death due to tumor: 0; survival time (month): 17.98
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325265
sample_title: Patient 28 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 28; age: 51.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 17.98; death due to tumor: 0; survival time (month): 17.98
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cb24a7e135ac70a5b77258cd66e9e2ebf8a93fe7df4d699750ce7809446e8ed1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 29 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 29; age: 73.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 6.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325266
sample_title: Patient 29 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 29; age: 73.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 6.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 25d3e984c7161147410b15aa3ce7909980a9206f6253e779faf0a532cad2f0b9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 30 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 30; age: 47.2; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.99; death due to tumor: 0; survival time (month): 13.12
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325267
sample_title: Patient 30 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 30; age: 47.2; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.99; death due to tumor: 0; survival time (month): 13.12
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a9a05834dbdb18270aad9b9a37e9c059c942c801192efaef336e0eaa0dce62b9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 31 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 31; age: 72.7; gender: F; tissue: rectal tumor; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 16.21; death due to tumor: 0; survival time (month): 16.21
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325268
sample_title: Patient 31 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 31; age: 72.7; gender: F; tissue: rectal tumor; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 16.21; death due to tumor: 0; survival time (month): 16.21
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9bad88d11ebcc155a0e7b08d1607eec5f89f7a6dc34664ca7a19f96d55d23160
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 32 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 32; age: 38.8; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 6.38; death due to tumor: 0; survival time (month): 6.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325269
sample_title: Patient 32 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 32; age: 38.8; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 6.38; death due to tumor: 0; survival time (month): 6.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: da73384c8d6f763d493969d41962dec7a6a56748cd157f067125d30c1f26920c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 33 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 33; age: 75.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325270
sample_title: Patient 33 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 33; age: 75.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 55617e0dc442b069c0ce4a8dad696abef25a40cd92c2571b73072bf05bbb64a7
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 34 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 34; age: 80; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.96; death due to tumor: 0; survival time (month): 2.96
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325271
sample_title: Patient 34 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 34; age: 80; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.96; death due to tumor: 0; survival time (month): 2.96
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3285627cb0fa3dec2e4a7930fe84e493ff7c600e1119de05c1b805902262ce67
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 35 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 35; age: 60.9; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.05; death due to tumor: 0; survival time (month): 13.05
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325272
sample_title: Patient 35 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 35; age: 60.9; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.05; death due to tumor: 0; survival time (month): 13.05
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 339c9e0e8c7d52038d9ded7ed1729259c4d1d9cfe842302447f7479fc0bb7a65
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 36 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 36; age: 76.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.74; death due to tumor: 0; survival time (month): 1.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325273
sample_title: Patient 36 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 36; age: 76.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.74; death due to tumor: 0; survival time (month): 1.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dd1c6f52771f09f46e013d50f91b776ad5485f0528c1947884236c64fe8252b8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 37 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 37; age: 49.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 12.59; death due to tumor: 0; survival time (month): 12.59
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325274
sample_title: Patient 37 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 37; age: 49.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 12.59; death due to tumor: 0; survival time (month): 12.59
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d661c5b9d3c4f9bd74ddeb772c7532f51c86f37f3ad50a3c294b3fdc948f2d40
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 38 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 38; age: 49.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 11.57; death due to tumor: 0; survival time (month): 11.57
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325275
sample_title: Patient 38 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 38; age: 49.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 11.57; death due to tumor: 0; survival time (month): 11.57
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 42235a250174e3020204c11ea99c736ee39d7284c14f0949ff08a51c4a67d205
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 39 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 39; age: 57.6; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 9.83; death due to tumor: 0; survival time (month): 9.83
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325276
sample_title: Patient 39 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 39; age: 57.6; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 9.83; death due to tumor: 0; survival time (month): 9.83
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 70fa19959d3979d2bdd145d184084b79181c4edbbfa9f61fcce3f262489fa963
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 40 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 40; age: 77.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.28; death due to tumor: 0; survival time (month): 8.28
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325277
sample_title: Patient 40 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 40; age: 77.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.28; death due to tumor: 0; survival time (month): 8.28
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ef55f107dfb89bfa41f971ede0c9fac5e57b573fc63aaffdda19d764a92b7b0d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 41 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 41; age: 72.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 22.68; death due to tumor: 0; survival time (month): 22.68
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325278
sample_title: Patient 41 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 41; age: 72.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 22.68; death due to tumor: 0; survival time (month): 22.68
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f94b6693e405f11619516224635a990b92261a0a65d10fba647bb4117b6d82a5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 42 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 42; age: 76.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 20.19; death due to tumor: 0; survival time (month): 20.19
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325279
sample_title: Patient 42 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 42; age: 76.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 20.19; death due to tumor: 0; survival time (month): 20.19
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ed930c44c92c2d16be55c264ac19e563490e80032b167f625c5226d409d93d6a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 43 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 43; age: 61.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325280
sample_title: Patient 43 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 43; age: 61.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ad3b3ea1539c449a3b18ae62c852a5e6bd7a9ad1ffa16546d6696c49cc5d0ebe
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 44 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 44; age: 66.3; gender: F; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325281
sample_title: Patient 44 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 44; age: 66.3; gender: F; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ce7591ccc5e2fb3bfd45dbb96ecf275278068730fc1f231e82fc54b280dd05de
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 45 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 45; age: 65.6; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325282
sample_title: Patient 45 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 45; age: 65.6; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 50f932fd2fba88e7bf932d25c8f2830684918b8782aa6b3e5b5150e7d49f2436
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 46 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 46; age: 68.4; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325283
sample_title: Patient 46 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 46; age: 68.4; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8327818bee09b7d117221d68546ccd362618ccab04dd4d272aba5c6005580f4a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 47 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 47; age: 78.9; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 0; metastasis before rct: NA; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325284
sample_title: Patient 47 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 47; age: 78.9; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 0; metastasis before rct: NA; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d80529178e853436de85bb5350b4f9cda78c0a160cd7864f451e27770d1da6eb
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 48 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 48; age: 65.8; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325285
sample_title: Patient 48 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 48; age: 65.8; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 63ab2f9d330e35b193894d606816dd42eace289b7c66e9348f504d406ad1afae
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 49 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 49; age: 57.1; gender: F; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325286
sample_title: Patient 49 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 49; age: 57.1; gender: F; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dfb4c322c6f728a6e7267bc1e647094146a7b48a2be4de3e821deb3da291f478
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 50 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 50; age: 74.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.03; death due to tumor: 0; survival time (month): 29.03
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325287
sample_title: Patient 50 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 50; age: 74.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.03; death due to tumor: 0; survival time (month): 29.03
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ece993b52ce7a3792613ad619300b30c88ba57cfb68febeadb0363ef5b417776
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 51 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 51; age: 48.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.78; death due to tumor: 0; survival time (month): 1.78
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325288
sample_title: Patient 51 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 51; age: 48.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.78; death due to tumor: 0; survival time (month): 1.78
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 24a95face61477d76aa2c3067a3bbef2995739086a0f7c8484157d8cd9701adc
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 52 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 52; age: 56.3; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0.69; death due to tumor: 0; survival time (month): 0.69
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325289
sample_title: Patient 52 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 52; age: 56.3; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0.69; death due to tumor: 0; survival time (month): 0.69
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 11be76338bfa8c6d1061a869315dbf0cea1ac98e7f0c2fd90188c25fd4a4fe41
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 53 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 53; age: 61.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 151.17; death due to tumor: 0; survival time (month): 151.17
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325290
sample_title: Patient 53 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 53; age: 61.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 151.17; death due to tumor: 0; survival time (month): 151.17
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 211cba0eda069a404ecda59e42761b658b64575c8443a0504ff106dba75622a9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 54 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 54; age: 65.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91; death due to tumor: 0; survival time (month): 91
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325291
sample_title: Patient 54 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 54; age: 65.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91; death due to tumor: 0; survival time (month): 91
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 689f8e73e287b0231a34ae776020b4dfc935e266ddfff83ee9c4dd653da452cc
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 55 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 55; age: 49.2; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 144.3; death due to tumor: 0; survival time (month): 144.3
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325292
sample_title: Patient 55 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 55; age: 49.2; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 144.3; death due to tumor: 0; survival time (month): 144.3
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e2a3d90cfa29a182bebc2aa0c5d186053a9dce835f4e9f9ab8ea534fe9fd2fe9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 56 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 56; age: 63.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.01; death due to tumor: 0; survival time (month): 112.01
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325293
sample_title: Patient 56 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 56; age: 63.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.01; death due to tumor: 0; survival time (month): 112.01
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 090a8a5f31262a8147c9de46f14d6f1ae9204cde910cbf69bc4b9b1aeadc98e3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 57 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 57; age: 58.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 111.25; death due to tumor: 0; survival time (month): 111.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325294
sample_title: Patient 57 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 57; age: 58.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 111.25; death due to tumor: 0; survival time (month): 111.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 166063433d4658c5c1798687b52a498f2ed955275e743c8af67d5645b899bc2f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 58 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 58; age: 66.4; gender: M; tissue: rectal tumor; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.04; death due to tumor: 0; survival time (month): 100.04
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325295
sample_title: Patient 58 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 58; age: 66.4; gender: M; tissue: rectal tumor; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.04; death due to tumor: 0; survival time (month): 100.04
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 65e82df49d2be3e205a9c09494e3b2e3f3a3e2f24dc1931ce3fab4df535966d0
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 59 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 59; age: 62.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 3.16; death due to tumor: 0; survival time (month): 3.16
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325296
sample_title: Patient 59 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 59; age: 62.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 3.16; death due to tumor: 0; survival time (month): 3.16
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 19d8c87019708d9a688fa497e2956c990207e3b8540061d8e88546c321132c45
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 60 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 60; age: 57.4; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.13; death due to tumor: 1; survival time (month): 70.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325297
sample_title: Patient 60 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 60; age: 57.4; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.13; death due to tumor: 1; survival time (month): 70.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 667985b674e85ee8858f9f7c062c5ec1a088af23f029b2b1962a0539e45c8d4a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 61 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 61; age: 48.4; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.24; death due to tumor: 0; survival time (month): 112.24
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325298
sample_title: Patient 61 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 61; age: 48.4; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.24; death due to tumor: 0; survival time (month): 112.24
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f106736741aa172bcd42d22986ea398dd56991f58ede74103c9242602cd557c8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 62 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 62; age: 71.2; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.53; death due to tumor: 0; survival time (month): 79.53
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325299
sample_title: Patient 62 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 62; age: 71.2; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.53; death due to tumor: 0; survival time (month): 79.53
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7b57ad3bbc33b58406e1ed5ab8f7cb8b2180a8f397851ee6e50ad5e41c406148
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 63 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 63; age: 71.2; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.84; death due to tumor: 0; survival time (month): 109.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325300
sample_title: Patient 63 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 63; age: 71.2; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.84; death due to tumor: 0; survival time (month): 109.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e64df95415d3d8165a3714122c1558f89b0a6988b8e9d91534ad1bff6832e765
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 64 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 64; age: 52.7; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 62.93; death due to tumor: 1; survival time (month): 110.17
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325301
sample_title: Patient 64 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 64; age: 52.7; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 62.93; death due to tumor: 1; survival time (month): 110.17
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6a8445b9fa4aefccedf61968ed17cd49889e9a023b60c0bd52843371045a6e42
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 65 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 65; age: 70.3; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 45.73; death due to tumor: 0; survival time (month): 45.73
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325302
sample_title: Patient 65 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 65; age: 70.3; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 45.73; death due to tumor: 0; survival time (month): 45.73
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 09340a3368ed2d4b8b9ddc03b4ac6835af43383cd8a6db009a1b918339acf64e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 66 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 66; age: 54; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 114.35; death due to tumor: 0; survival time (month): 114.35
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325303
sample_title: Patient 66 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 66; age: 54; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 114.35; death due to tumor: 0; survival time (month): 114.35
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 5fae8f4ebfa941c2f47fd8d164171a3250d34bbd0ae3075230f9efdca738542d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 67 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 67; age: 53.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 58.92; death due to tumor: 1; survival time (month): 84.36
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325304
sample_title: Patient 67 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 67; age: 53.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 58.92; death due to tumor: 1; survival time (month): 84.36
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4147080652c0c025895d8655a733e611585492686010d2f8b27823915f09f416
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 68 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 68; age: 60; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.79; death due to tumor: 0; survival time (month): 86.79
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325305
sample_title: Patient 68 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 68; age: 60; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.79; death due to tumor: 0; survival time (month): 86.79
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b048c8ed6e848ae940e26764d019ae72cbb24a16cb26a40c8510bdea7668a50d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 69 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 69; age: 68.2; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 93.96; death due to tumor: 0; survival time (month): 93.96
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325306
sample_title: Patient 69 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 69; age: 68.2; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 93.96; death due to tumor: 0; survival time (month): 93.96
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4e10ba880d0cd4a1641b870a950a6d44ca68cd8415b9fb92b21cd949ae4e9124
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 70 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 70; age: 65.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 25.38; death due to tumor: 1; survival time (month): 51.52
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325307
sample_title: Patient 70 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 70; age: 65.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 25.38; death due to tumor: 1; survival time (month): 51.52
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1a98447888490d2a941d4dd6979703bdde1209c1a751a526b369f29c0cfe4670
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 71 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 71; age: 79.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.27; death due to tumor: 0; survival time (month): 88.27
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325308
sample_title: Patient 71 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 71; age: 79.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.27; death due to tumor: 0; survival time (month): 88.27
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 794a3537a711d3c12798b7a1d05e1bb60aa455d61c095df2416b8aa287fdd48b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 72 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 72; age: 81.4; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.98; death due to tumor: 0; survival time (month): 82.98
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325309
sample_title: Patient 72 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 72; age: 81.4; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.98; death due to tumor: 0; survival time (month): 82.98
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1cc80ed447c4e93e486e58ce645a55165f494ac6ab3ed3b4bf1ddf52c9709bb7
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 73 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 73; age: 66.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.31; death due to tumor: 0; survival time (month): 71.31
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325310
sample_title: Patient 73 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 73; age: 66.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.31; death due to tumor: 0; survival time (month): 71.31
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8c776c67c5f7aab942572f4460bf329b472b3a3283c8518ec307ed503f9fa573
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 74 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 74; age: 59.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 61.25; death due to tumor: 0; survival time (month): 61.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325311
sample_title: Patient 74 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 74; age: 59.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 61.25; death due to tumor: 0; survival time (month): 61.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 03f268832511551ac18f52e93436a4d716939d91508844ef6fde6fad1103e93f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 75 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 75; age: 57.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 83.97; death due to tumor: 0; survival time (month): 83.97
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325312
sample_title: Patient 75 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 75; age: 57.4; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 83.97; death due to tumor: 0; survival time (month): 83.97
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 30feb938c0a96769e3d71a5b49c83c2d97ec86e967c9f953790082d01f596751
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 76 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 76; age: 81.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 39.25; death due to tumor: 0; survival time (month): 39.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325313
sample_title: Patient 76 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 76; age: 81.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 39.25; death due to tumor: 0; survival time (month): 39.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7664d0589f81859f8da8e0033660f822cf587e45ab52c25cb22bb39ebbe5139f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 77 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 77; age: 62.3; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.39; death due to tumor: 0; survival time (month): 34.39
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325314
sample_title: Patient 77 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 77; age: 62.3; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.39; death due to tumor: 0; survival time (month): 34.39
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 344829acf804f4f942cc97203c09a912956bebe6af802154a7cef208aa583ba1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 78 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 78; age: 63.7; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.83; death due to tumor: 0; survival time (month): 88.83
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325315
sample_title: Patient 78 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 78; age: 63.7; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.83; death due to tumor: 0; survival time (month): 88.83
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 49fd0b3c5e7c0ed32ac5e535c9842051c7c0e64dc500c1c3704898476f678384
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 79 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 79; age: 66.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.63; death due to tumor: 0; survival time (month): 79.63
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325316
sample_title: Patient 79 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 79; age: 66.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.63; death due to tumor: 0; survival time (month): 79.63
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d5fe0f6bc10ced34570723eea9d85242f21b56cab85054759c02add521d0f1e3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 80 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 80; age: 71.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 73.48; death due to tumor: 0; survival time (month): 82.82
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325317
sample_title: Patient 80 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 80; age: 71.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 73.48; death due to tumor: 0; survival time (month): 82.82
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: aed1306f2a612055b1389d40f649545a5019e7fde3ff3a4ede7a3536a69e5a75
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 81 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 81; age: 76.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.85; death due to tumor: 0; survival time (month): 77.85
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325318
sample_title: Patient 81 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 81; age: 76.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.85; death due to tumor: 0; survival time (month): 77.85
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ca307a2d443b91cd3dfc968364fbb21e1196645f4099643683db1d91b907a513
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 82 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 82; age: 76.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.48; death due to tumor: 0; survival time (month): 75.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325319
sample_title: Patient 82 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 82; age: 76.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.48; death due to tumor: 0; survival time (month): 75.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dc23a5d927363118d07fff390bf8f07d69027bb4de9c04180539fc6b205aacfe
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 83 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 83; age: 58.3; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.03; death due to tumor: 0; survival time (month): 96.03
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325320
sample_title: Patient 83 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 83; age: 58.3; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.03; death due to tumor: 0; survival time (month): 96.03
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 437dce0de92e811adf2efce58bf004569defba7172f6154a6150d9e50ccec5c6
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 84 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 84; age: 76.7; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 98.7; death due to tumor: 0; survival time (month): 98.7
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325321
sample_title: Patient 84 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 84; age: 76.7; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 98.7; death due to tumor: 0; survival time (month): 98.7
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6da8c3288f6b0b4102991f1bf01eb45cebf251ccc257e33b63366aed9b5d2c4c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 85 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 85; age: 62.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 34.06; death due to tumor: 1; survival time (month): 79.5
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325322
sample_title: Patient 85 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 85; age: 62.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 34.06; death due to tumor: 1; survival time (month): 79.5
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7bb873cd90d0d1ce05f4c68130d5d6ced62de0c531b29c15fcf4ecda33a7f718
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 86 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 86; age: 51.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 76.87; death due to tumor: 0; survival time (month): 76.87
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325323
sample_title: Patient 86 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 86; age: 51.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 76.87; death due to tumor: 0; survival time (month): 76.87
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3dbe6d3f694b8e37e5801bc1b59868ff632097096f28f0f397e8b0cacc370cb1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 87 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 87; age: 67.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.82; death due to tumor: 0; survival time (month): 29.82
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325324
sample_title: Patient 87 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 87; age: 67.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.82; death due to tumor: 0; survival time (month): 29.82
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3f01022dbc2d3db495914e647f6f2e8f772448daf78d8f80c5daab10b53bf581
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 88 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 88; age: 63.4; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 90.02; death due to tumor: 0; survival time (month): 90.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325325
sample_title: Patient 88 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 88; age: 63.4; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 90.02; death due to tumor: 0; survival time (month): 90.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a3e9d46b97d67a661ed0c29fa7d88dc372090149b9336180f87dcc00ea104ac9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 89 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 89; age: 76.3; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.61; death due to tumor: 0; survival time (month): 71.61
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325326
sample_title: Patient 89 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 89; age: 76.3; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.61; death due to tumor: 0; survival time (month): 71.61
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: bcf49efeb358eece3c87479eac1b14118ef0b57186ca0526dc88aa5162c612f0
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 90 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 90; age: 41.8; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 94.26; death due to tumor: 0; survival time (month): 94.26
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325327
sample_title: Patient 90 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 90; age: 41.8; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 94.26; death due to tumor: 0; survival time (month): 94.26
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f2dbd07e4438a67808f903f5310721b03642bfb46efba731d53feb6b3fcb5919
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 91 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 91; age: 58.1; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.63; death due to tumor: 0; survival time (month): 91.63
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325328
sample_title: Patient 91 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 91; age: 58.1; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.63; death due to tumor: 0; survival time (month): 91.63
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 06aa5666cc430d920e1e389d52e2dc6ab6751f111fe1a2377a1e215194f477ec
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 92 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 92; age: 65.8; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.79; death due to tumor: 0; survival time (month): 60.79
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325329
sample_title: Patient 92 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 92; age: 65.8; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.79; death due to tumor: 0; survival time (month): 60.79
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3095a761086c4a0988706f0f733a647fbff3794f77e2b72b5b1be98fbe90a3f5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 93 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 93; age: 59.5; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.52; death due to tumor: 0; survival time (month): 63.52
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325330
sample_title: Patient 93 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 93; age: 59.5; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.52; death due to tumor: 0; survival time (month): 63.52
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9f650f2b49b127af1a4322899b5edf8ccf893750ea46e7ad49d3357087652c85
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 94 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 94; age: 53.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.12; death due to tumor: 1; survival time (month): 33.6
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325331
sample_title: Patient 94 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 94; age: 53.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.12; death due to tumor: 1; survival time (month): 33.6
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7239e0a92b7a2928841931c4cbb7f941348581dcafe0976df451c91a53c7a7aa
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 95 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 95; age: 56.9; gender: M; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 87.35; death due to tumor: 0; survival time (month): 87.35
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325332
sample_title: Patient 95 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 95; age: 56.9; gender: M; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 87.35; death due to tumor: 0; survival time (month): 87.35
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 300b86d5e80762b3da24128665c7d07dd41aa1c654eb5782009242dddb6221ce
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 96 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 96; age: 60.7; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.32; death due to tumor: 0; survival time (month): 109.32
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325333
sample_title: Patient 96 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 96; age: 60.7; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.32; death due to tumor: 0; survival time (month): 109.32
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8be7c4d715b9205db40a864c1a228423dac6910d1c8f88e4605c5c0b6b30ba6d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 97 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 97; age: 64.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 46.62; death due to tumor: 1; survival time (month): 73.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325334
sample_title: Patient 97 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 97; age: 64.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 46.62; death due to tumor: 1; survival time (month): 73.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3089e60d47e06c5c7dedc1aac79332eda8c6b0b105769ee66607162817d38e83
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 98 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 98; age: 55.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.78; death due to tumor: 1; survival time (month): 25.51
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325335
sample_title: Patient 98 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 98; age: 55.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.78; death due to tumor: 1; survival time (month): 25.51
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6523827e272b82ee0283e949b915bf66ec3225be2898ca5cf127aa1be33f0c87
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 99 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 99; age: 50; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.62; death due to tumor: 0; survival time (month): 105.14
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325336
sample_title: Patient 99 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 99; age: 50; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.62; death due to tumor: 0; survival time (month): 105.14
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e22eaa193fbf417e18c103ce6a4e3157a448e1af6dbb68c14afdef44ee7184b3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 100 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 100; age: 35.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 68.65; death due to tumor: 1; survival time (month): 91.53
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325337
sample_title: Patient 100 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 100; age: 35.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 68.65; death due to tumor: 1; survival time (month): 91.53
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6b17396dbd1b2ef799671f33bb375fe4048e5095e63d65d096196864b645b3f8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 101 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 101; age: 77.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.13; death due to tumor: 0; survival time (month): 91.13
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325338
sample_title: Patient 101 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 101; age: 77.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.13; death due to tumor: 0; survival time (month): 91.13
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dacf8d483a1007d74dac2af38b0fa10c434c25e6985f3dbcba900ff3d1526848
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 102 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 102; age: 65.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.79; death due to tumor: 0; survival time (month): 79.79
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325339
sample_title: Patient 102 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 102; age: 65.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.79; death due to tumor: 0; survival time (month): 79.79
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2aa709346483abe4046990bd9926b4f5e63b93913609b365b5c407272ecc711a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 103 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 103; age: 74.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.64; death due to tumor: 1; survival time (month): 24.39
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325340
sample_title: Patient 103 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 103; age: 74.6; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.64; death due to tumor: 1; survival time (month): 24.39
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9dd19bd86561ef78850431a7bb0fcf88bb4a8ad73b2d58a8421334c26b97efbc
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 104 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 104; age: 63; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.7; death due to tumor: 0; survival time (month): 100.7
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325341
sample_title: Patient 104 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 104; age: 63; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.7; death due to tumor: 0; survival time (month): 100.7
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 19450c24543cbabc1b6334359a41a53f621e4c68eca9e9b9169c04940b71ed75
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 105 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 105; age: 73.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 85.84; death due to tumor: 0; survival time (month): 85.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325342
sample_title: Patient 105 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 105; age: 73.3; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 85.84; death due to tumor: 0; survival time (month): 85.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0ce9f02f62be06ef11ecb5abc3646d4f451f2ba83e626cbd51b192421a3488d4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 106 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 106; age: 73.3; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.72; death due to tumor: 0; survival time (month): 75.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325343
sample_title: Patient 106 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 106; age: 73.3; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.72; death due to tumor: 0; survival time (month): 75.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2bf19699d0efec771599ee6f699ee84ba914ed3042ca763a3cd5a986c9a79688
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 107 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 107; age: 54.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.11; death due to tumor: 0; survival time (month): 78.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325344
sample_title: Patient 107 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 107; age: 54.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.11; death due to tumor: 0; survival time (month): 78.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 41d735b6a63f059822da646c660b425d17e0fa1425f3d01ddf72d5660c4f30c8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 108 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 108; age: 61.5; gender: M; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.4; death due to tumor: 0; survival time (month): 2.4
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325345
sample_title: Patient 108 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 108; age: 61.5; gender: M; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.4; death due to tumor: 0; survival time (month): 2.4
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2d2939f8f76f6e5264f308ac7b8e795a4f801fe0e5bb775ec4c548c60a612b7a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 109 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 109; age: 63.2; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 14.99; death due to tumor: 1; survival time (month): 29.46
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325346
sample_title: Patient 109 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 109; age: 63.2; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 14.99; death due to tumor: 1; survival time (month): 29.46
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 18f7509537138ef283256c8bc910aef0ab8eb39bbcb9a0fe9b7ba14baa004f33
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 110 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 110; age: 63.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.05; death due to tumor: 0; survival time (month): 23.05
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325347
sample_title: Patient 110 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 110; age: 63.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.05; death due to tumor: 0; survival time (month): 23.05
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 02b2f8fcf338d1c17b24a1c2872ec7ce4c7df57ec257a36ac87dc23620eb322c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 111 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 111; age: 75.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.82; death due to tumor: 1; survival time (month): 20.32
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325348
sample_title: Patient 111 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 111; age: 75.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.82; death due to tumor: 1; survival time (month): 20.32
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 06be549ee32207ed6de5839dcf5581966da6db443b2086591fd5b67f72322e59
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 112 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 112; age: 68.3; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 95.74; death due to tumor: 0; survival time (month): 95.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325349
sample_title: Patient 112 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 112; age: 68.3; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 95.74; death due to tumor: 0; survival time (month): 95.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 17685c25aa07ac8fa89f34b09f1f283b8a5102bc1a16bc7a779af9805750ec26
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 113 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 113; age: 51.1; gender: F; tissue: rectal tumor; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.18; death due to tumor: 0; survival time (month): 36.33
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325350
sample_title: Patient 113 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 113; age: 51.1; gender: F; tissue: rectal tumor; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.18; death due to tumor: 0; survival time (month): 36.33
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: afcda685577b3cb88b37a67e522d9b814f8c76b30c238e19f83766e5a63fe07e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 114 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 114; age: 46.3; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.13; death due to tumor: 0; survival time (month): 96.13
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325351
sample_title: Patient 114 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 114; age: 46.3; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.13; death due to tumor: 0; survival time (month): 96.13
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0652fc001d1071f4724a90fb725183d0f44b5d3bfa2c446253b7f7e8963a1b5f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 115 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 115; age: 59.4; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325352
sample_title: Patient 115 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 115; age: 59.4; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f1a18323d3fc7a23703ca75e86554b51235fdbae288a0722fb339cacd97df409
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 116 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 116; age: 70.9; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.14; death due to tumor: 0; survival time (month): 45.57
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325353
sample_title: Patient 116 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 116; age: 70.9; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.14; death due to tumor: 0; survival time (month): 45.57
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b0e4f187574d489199b51a82357fd38765304403cdf3f477defcd4a8f9e753db
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 117 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 117; age: 59.8; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.87; death due to tumor: 0; survival time (month): 64.87
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325354
sample_title: Patient 117 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 117; age: 59.8; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.87; death due to tumor: 0; survival time (month): 64.87
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 01c8f75cc2ea91271704e5a7c220c9b70d0da7f533c34a75deb289a014fcc2f1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 118 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 118; age: 81.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 44.61; death due to tumor: 0; survival time (month): 44.61
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325355
sample_title: Patient 118 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 118; age: 81.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 44.61; death due to tumor: 0; survival time (month): 44.61
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 36636913b88875f7ef35b09f01ba867ebc4c5a40dae91a55830bd01e2f59fdc9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 119 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 119; age: 73; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.19; death due to tumor: 0; survival time (month): 70.19
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325356
sample_title: Patient 119 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 119; age: 73; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.19; death due to tumor: 0; survival time (month): 70.19
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 81223b575457bfed01171be283199d783ba5aca5fade8568a9299db7574ff7ab
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 120 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 120; age: 70.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.74; death due to tumor: 0; survival time (month): 71.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325357
sample_title: Patient 120 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 120; age: 70.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.74; death due to tumor: 0; survival time (month): 71.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ba3eff82d171f154d7ad01ea2a919d744084ff142d25936ddbaa551554e8ff0d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 121 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 121; age: 63.8; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.99; death due to tumor: 1; survival time (month): 49.91
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325358
sample_title: Patient 121 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 121; age: 63.8; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.99; death due to tumor: 1; survival time (month): 49.91
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4974ece5f6d7a55483d05eb5b42b8bb1f04d765efb6197d0895ddc2825cc4fbe
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 122 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 122; age: 63.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.42; death due to tumor: 0; survival time (month): 63.42
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325359
sample_title: Patient 122 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 122; age: 63.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.42; death due to tumor: 0; survival time (month): 63.42
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4e5b154a0eefea4c4cc4fb765a8bb29e29c1ea6691e91a71eeac381062aed723
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 123 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 123; age: 72.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 91.43
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325360
sample_title: Patient 123 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 123; age: 72.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 91.43
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3bc1f216b29791d8ccbd5344235b9b64e13eaf74915849399681fc3a27190c7a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 124 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 124; age: 51.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.19; death due to tumor: 1; survival time (month): 8.81
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325361
sample_title: Patient 124 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 124; age: 51.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.19; death due to tumor: 1; survival time (month): 8.81
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 33b63a946907d6264f4a356b47d2e69efa354db5b21538cd4040d56e9f625a13
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 125 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 125; age: 69.6; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.72; death due to tumor: 0; survival time (month): 63.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325362
sample_title: Patient 125 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 125; age: 69.6; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.72; death due to tumor: 0; survival time (month): 63.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4957f7e31934ffd3da03bd2544c65b33d17343d73d282dc4bc1a2d63c03a2722
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 126 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 126; age: 65.1; gender: F; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.53; death due to tumor: 0; survival time (month): 60.53
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325363
sample_title: Patient 126 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 126; age: 65.1; gender: F; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.53; death due to tumor: 0; survival time (month): 60.53
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8245799282503e2e0b9e8e34ff75d0adcba6e4d5dd03898d08105c408185c05e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 127 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 127; age: 60.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.84; death due to tumor: 0; survival time (month): 73.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325364
sample_title: Patient 127 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 127; age: 60.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.84; death due to tumor: 0; survival time (month): 73.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fffd2095780a38afdbd76b8c5d862edf21f66daf49db864abdc429604ad924ee
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 128 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 128; age: 56.3; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 65.72; death due to tumor: 0; survival time (month): 65.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325365
sample_title: Patient 128 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 128; age: 56.3; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 65.72; death due to tumor: 0; survival time (month): 65.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1325020516aa605e6dbb22b59d0b7d3205b70cc4262cc1dcfbf1398f02e8aff8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 129 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 129; age: 66.2; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.46; death due to tumor: 0; survival time (month): 60.46
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325366
sample_title: Patient 129 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 129; age: 66.2; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.46; death due to tumor: 0; survival time (month): 60.46
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 314741be8706d1660e6a2f8f8dc6af1d82b3232fd54022de43d9dd11be5f0c62
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 130 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 130; age: 79.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325367
sample_title: Patient 130 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 130; age: 79.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 434ec214277b32c9da1175d19782155ff9796e167108d844cac5fa674fdbebe3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 131 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 131; age: 67.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 68.48; death due to tumor: 0; survival time (month): 68.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325368
sample_title: Patient 131 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 131; age: 67.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 68.48; death due to tumor: 0; survival time (month): 68.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a39a3d3e458250feb627bd2ebba4c38918e49d860cce8f5d8abcd9907607336d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 132 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 132; age: 60.6; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.09; death due to tumor: 0; survival time (month): 63.09
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325369
sample_title: Patient 132 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 132; age: 60.6; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.09; death due to tumor: 0; survival time (month): 63.09
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: de7768dc86ee4bac1f61affcda8f8505be0546f0f4af7d0c144ec50307075aa5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 133 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 133; age: 51.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.24; death due to tumor: 0; survival time (month): 71.24
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325370
sample_title: Patient 133 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 133; age: 51.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.24; death due to tumor: 0; survival time (month): 71.24
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ebf0654875ef64221f4abd2ce4639d2328cfdff519ee971dbb69c76b2a133894
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 134 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 134; age: 57.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 3.32
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325371
sample_title: Patient 134 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 134; age: 57.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 3.32
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fc8d3b295d8dfd5b99d66915f981497038f558cc95fd9d9e0eb04d282391c94a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 135 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 135; age: 54.8; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325372
sample_title: Patient 135 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 135; age: 54.8; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1e41fa5e063795f911b74d03f01f1ed9e72b43983e56196db532a3e05bf69ce6
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 136 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 136; age: 73.7; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.13; death due to tumor: 0; survival time (month): 61.41
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325373
sample_title: Patient 136 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 136; age: 73.7; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.13; death due to tumor: 0; survival time (month): 61.41
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 364b4c492713d4801e1a87d7b34d3158239f65f041a3727f08027b682ab98f3f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 137 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 137; age: 73.9; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 23.01; death due to tumor: 1; survival time (month): 42.97
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325374
sample_title: Patient 137 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 137; age: 73.9; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 23.01; death due to tumor: 1; survival time (month): 42.97
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 10def74c136e082fe7f218b402e5ded606ed768e623c84346d10acf778745771
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 138 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 138; age: 50.5; gender: F; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 42.54; death due to tumor: 0; survival time (month): 42.54
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325375
sample_title: Patient 138 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 138; age: 50.5; gender: F; tissue: rectal tumor; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 42.54; death due to tumor: 0; survival time (month): 42.54
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: acf96ccc013e3a14bc3d7b7130f0867e44906fa61009001c74a821f7a827f3be
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 139 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 139; age: 77; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.88; death due to tumor: 0; survival time (month): 82.88
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325376
sample_title: Patient 139 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 139; age: 77; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.88; death due to tumor: 0; survival time (month): 82.88
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a7f990da535e0ec1bed476136f9fc0ca9cbff7f00012fe4c5fbea59e6805b329
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 140 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 140; age: 41.8; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.8; death due to tumor: 0; survival time (month): 71.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325377
sample_title: Patient 140 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 140; age: 41.8; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.8; death due to tumor: 0; survival time (month): 71.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b12fafef659ae8f49b69f3d9899995ee88976755eb20802c0cd3afd77494c376
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 141 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 141; age: 73.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.48; death due to tumor: 0; survival time (month): 63.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325378
sample_title: Patient 141 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 141; age: 73.1; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.48; death due to tumor: 0; survival time (month): 63.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 43bc1aae8d18c9907ca6cb0a80fe6518ef15a4e82b617b3b0ddfb64aab6c1a44
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 142 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 142; age: 67; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 78.71; death due to tumor: 0; survival time (month): 78.71
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325379
sample_title: Patient 142 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 142; age: 67; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 78.71; death due to tumor: 0; survival time (month): 78.71
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dfa77efcbd5009dbc0a34d50eddb909f20d28414ec53e52a0838513b7d10a474
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 143 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 143; age: 61.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325380
sample_title: Patient 143 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 143; age: 61.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d8a0bb4964c51f8ffb3586271a6ad74290b889df8389abdc1e6563c962ff4e67
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 144 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 144; age: 42; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.59; death due to tumor: 0; survival time (month): 77.59
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325381
sample_title: Patient 144 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 144; age: 42; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.59; death due to tumor: 0; survival time (month): 77.59
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d0de01c06a97c3807135b22fc4744b5d776182e5f1cb7976cc3c003196eb7305
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 145 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 145; age: 68.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.67; death due to tumor: 0; survival time (month): 40.67
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325382
sample_title: Patient 145 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 145; age: 68.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.67; death due to tumor: 0; survival time (month): 40.67
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9897dc41c08857cc7a3943cf33affaa95d0f4f4b925c8ad1cb3934a393e91016
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 146 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 146; age: 59.4; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 35.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325383
sample_title: Patient 146 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 146; age: 59.4; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 35.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a02d1c86f2a3956ede06032f7b01c6012c3f303ab34fc329d7f4f42590c5b503
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 147 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 147; age: 78.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.5; death due to tumor: 0; survival time (month): 64.5
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325384
sample_title: Patient 147 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 147; age: 78.8; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.5; death due to tumor: 0; survival time (month): 64.5
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ebb8a5e30726f4c9b14537a240f5a8f6cd73b8331b832c29da62c39d62828154
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 148 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 148; age: 57.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.56; death due to tumor: 0; survival time (month): 72.56
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325385
sample_title: Patient 148 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 148; age: 57.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.56; death due to tumor: 0; survival time (month): 72.56
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0805905fd7a4de76b06623167f56408f1c49d7e0fa16c56d85758525cb4c650f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 149 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 149; age: 63.7; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 74.33; death due to tumor: 0; survival time (month): 74.33
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325386
sample_title: Patient 149 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 149; age: 63.7; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 74.33; death due to tumor: 0; survival time (month): 74.33
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ec27dac3f3476329d650ce19600bc7e45b65311ded5d5a753e26c92b22400dd7
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 150 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 150; age: 60.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.32; death due to tumor: 1; survival time (month): 40.83
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325387
sample_title: Patient 150 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 150; age: 60.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.32; death due to tumor: 1; survival time (month): 40.83
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 336ab3125af12b7884087d3a4ec29e0494b64196da93d5762c38b2e4ba7798b5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 151 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 151; age: 62.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.1; death due to tumor: 0; survival time (month): 72.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325388
sample_title: Patient 151 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 151; age: 62.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.1; death due to tumor: 0; survival time (month): 72.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6b61321ece5986c70f32c8e4664fd80b863c3dc1ee85581e014fd8ce2fcbf73b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 152 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 152; age: 51.7; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 69.04; death due to tumor: 0; survival time (month): 69.04
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325389
sample_title: Patient 152 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 152; age: 51.7; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 69.04; death due to tumor: 0; survival time (month): 69.04
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b4124585d64a939eb75791b5d47623bc56f8b5dc8d9b06fec38b34cbdeedb7ac
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 153 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 153; age: 56.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.09; death due to tumor: 0; survival time (month): 70.09
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325390
sample_title: Patient 153 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 153; age: 56.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.09; death due to tumor: 0; survival time (month): 70.09
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 74d196034ffcf7076d12746a1d6cfaf385ca85def9338055f5d43ea80917e71d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 154 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 154; age: 74.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.2; death due to tumor: 0; survival time (month): 2.2
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325391
sample_title: Patient 154 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 154; age: 74.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.2; death due to tumor: 0; survival time (month): 2.2
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b6762b101e6631b6180a63fdaaf04707b2277344fd4c44313899ac78e4750947
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 155 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 155; age: 61.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.54; death due to tumor: 0; survival time (month): 71.54
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325392
sample_title: Patient 155 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 155; age: 61.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.54; death due to tumor: 0; survival time (month): 71.54
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6634f6c81b8ff05f6ab04f3fa259f689d2fcfe437d1fbdcd8276a2bf1c63e84f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 156 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 156; age: 69.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 67.76; death due to tumor: 0; survival time (month): 67.76
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325393
sample_title: Patient 156 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 156; age: 69.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 67.76; death due to tumor: 0; survival time (month): 67.76
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fda2b6d317e038fcceee36b3be6c83f1666c3845784d53096346fd1b7fcf2d79
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 157 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 157; age: 63.6; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.03; death due to tumor: 0; survival time (month): 72.03
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325394
sample_title: Patient 157 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 157; age: 63.6; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.03; death due to tumor: 0; survival time (month): 72.03
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 50cee77bcb75d38cf81ac89c7171c8eb8b0b87c7f8579111b1d33cf19200b9ef
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 158 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 158; age: 59; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 8.45; death due to tumor: 1; survival time (month): 27.12
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325395
sample_title: Patient 158 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 158; age: 59; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 8.45; death due to tumor: 1; survival time (month): 27.12
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9a41fa4f6d9544f29408496208f7359e7045f9b90068725cf3dbe444760d9458
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 159 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 159; age: 53.1; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 59.8; death due to tumor: 0; survival time (month): 59.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325396
sample_title: Patient 159 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 159; age: 53.1; gender: F; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 59.8; death due to tumor: 0; survival time (month): 59.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: c66d066534f35a478f104a7cbfba1153083dbebe602525339a3322ec858e030e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 160 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 160; age: 65.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 37.02; death due to tumor: 0; survival time (month): 37.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325397
sample_title: Patient 160 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 160; age: 65.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 37.02; death due to tumor: 0; survival time (month): 37.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e87303690d2fe9b01d8681f6bf27b92929e9162c1b8d310d952b431ee6e3a5a5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 161 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 161; age: 70.6; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.36; death due to tumor: 0; survival time (month): 29.36
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325398
sample_title: Patient 161 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 161; age: 70.6; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.36; death due to tumor: 0; survival time (month): 29.36
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b161f510377fcb19b488cb8f215e5b18a7d9d819949300ffca61d2a8167d60d1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 162 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 162; age: 46.2; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 50.14; death due to tumor: 0; survival time (month): 50.14
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325399
sample_title: Patient 162 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 162; age: 46.2; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 50.14; death due to tumor: 0; survival time (month): 50.14
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fa668188205649b59876a0e7be81414c7368a8ebfb987603b691e246336ea86a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 163 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 163; age: 63.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 16.73; death due to tumor: 0; survival time (month): 16.73
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325400
sample_title: Patient 163 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 163; age: 63.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 16.73; death due to tumor: 0; survival time (month): 16.73
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 5c1dc7af22b8b0c315a20e112580d53fe741517c2f042ac6a29b3b08f8f01cd8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 164 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 164; age: 47.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.1; death due to tumor: 0; survival time (month): 7.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325401
sample_title: Patient 164 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 164; age: 47.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.1; death due to tumor: 0; survival time (month): 7.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7d9f4314f255291520d33a1dbbd775a3d6fb559534ae919e869d4f0e9b94fb4b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 165 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 165; age: 77.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.73; death due to tumor: 0; survival time (month): 7.73
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325402
sample_title: Patient 165 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 165; age: 77.7; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.73; death due to tumor: 0; survival time (month): 7.73
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ae46f399edcda446d9db26e207b72e1fb5a0d2f836ff02dcb05342ced8261f9f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 166 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 166; age: 56.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325403
sample_title: Patient 166 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 166; age: 56.5; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f3292f22e14e90a25a5c8d5e010c046b950f7e77f4243f07abb40eadfb2df39b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 167 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 167; age: 52.4; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 11.9; death due to tumor: 0; survival time (month): 11.9
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325404
sample_title: Patient 167 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 167; age: 52.4; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 11.9; death due to tumor: 0; survival time (month): 11.9
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3a2c4893ab167e354dacbe7f316442cc56f81fcfc0f3b9e840dace54c933d38a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 168 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 168; age: 59.1; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325405
sample_title: Patient 168 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 168; age: 59.1; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0400810b8d0e8d7c10749a0f880d785e72b9d4a90f5090ae5959b4e3e6524ae4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 169 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 169; age: 69; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 5.85; death due to tumor: 0; survival time (month): 5.85
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325406
sample_title: Patient 169 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 169; age: 69; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 5.85; death due to tumor: 0; survival time (month): 5.85
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: c08d0efaf6d900b96ac834584a33ab73e8b94445dc1da818e3ceb3088034379e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 170 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 170; age: 64.3; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325407
sample_title: Patient 170 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 170; age: 64.3; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0d504b1ed772a6cb770d612b5f944b79157b3ab4b00f174e9897322bc2490633
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 171 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 171; age: 65.7; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325408
sample_title: Patient 171 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 171; age: 65.7; gender: M; tissue: rectal tumor; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cc3f440260bd946067dc11cc26b5e02179bcc2213bae7c7a0c565e1df1c0b27d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 172 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 172; age: 65.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 5.39; death due to tumor: 0; survival time (month): 5.39
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325409
sample_title: Patient 172 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 172; age: 65.2; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 5.39; death due to tumor: 0; survival time (month): 5.39
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3f2bb8aafeff351378543d39b977ae728e0605389a3de186347eb1ff801ec213
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 173 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 173; age: 47.6; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325410
sample_title: Patient 173 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 173; age: 47.6; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 134510bb044ec3407cc8ab9436cb2f35564191cda60f9faaae6afdede59b2bb3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 174 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 174; age: 60.3; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 110.96; death due to tumor: 0; survival time (month): 110.96
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325411
sample_title: Patient 174 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 174; age: 60.3; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 110.96; death due to tumor: 0; survival time (month): 110.96
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1a19bacb8df7b0d56bb3209ef7d52c95c140cd37792c37ef73b719a394d687e7
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 175 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 175; age: 70.9; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 152.48; death due to tumor: 0; survival time (month): 152.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325412
sample_title: Patient 175 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 175; age: 70.9; gender: F; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 152.48; death due to tumor: 0; survival time (month): 152.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0201f7c92b539e6e4cea91fbe1f9375a5e44d76c3a74d41601c68579c238f02f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 176 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 176; age: 56.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 126.74; death due to tumor: 0; survival time (month): 126.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325413
sample_title: Patient 176 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 176; age: 56.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 126.74; death due to tumor: 0; survival time (month): 126.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: bf51dc3802bcca6b21bcb46a60c42d248d796a80377752bedaf7daf7950f614a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 177 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 177; age: 53.7; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 143.41; death due to tumor: 0; survival time (month): 143.41
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325414
sample_title: Patient 177 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 177; age: 53.7; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 143.41; death due to tumor: 0; survival time (month): 143.41
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 07211ddba92360c77ab5e38f7844d9b9b2b06dfd6ef8633179a59919e4ef610d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 178 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 178; age: 55.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.66; death due to tumor: 0; survival time (month): 96.66
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325415
sample_title: Patient 178 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 178; age: 55.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.66; death due to tumor: 0; survival time (month): 96.66
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f101d4a0e6cf6068e549b6a1429022d8a5897b4895dc95e3735392d766ee3b84
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 179 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 179; age: 61.6; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.47; death due to tumor: 1; survival time (month): 57.93
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325416
sample_title: Patient 179 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 179; age: 61.6; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.47; death due to tumor: 1; survival time (month): 57.93
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8351c21f168e986c63c8d7362a06957f8d4fefc3ffe96302ff724278838809b4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 180 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 180; age: 59.3; gender: M; tissue: rectal tumor; kras mutation: G12W; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 5.52; death due to tumor: 1; survival time (month): 21.44
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325417
sample_title: Patient 180 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 180; age: 59.3; gender: M; tissue: rectal tumor; kras mutation: G12W; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 5.52; death due to tumor: 1; survival time (month): 21.44
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1cfd3bd87d3c567ea89903ceed8be4c85f20ffe3bcb86680fc87393f7b1e0e8b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 181 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 181; age: 62.5; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 11.64; death due to tumor: 1; survival time (month): 85.64
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325418
sample_title: Patient 181 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 181; age: 62.5; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 11.64; death due to tumor: 1; survival time (month): 85.64
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cac403175d1ca3c7af2b545b41341e07ef99c50872db16ef9820e63aaef60bc5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 182 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 182; age: 68.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 103.1; death due to tumor: 0; survival time (month): 103.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325419
sample_title: Patient 182 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 182; age: 68.5; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 103.1; death due to tumor: 0; survival time (month): 103.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e58ef4b9fd4be7a46934b8cae452b6eaf4099e92d712ce8f237438aab30e13a7
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 183 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 183; age: 62.6; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.33; death due to tumor: 0; survival time (month): 143.54
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325420
sample_title: Patient 183 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 183; age: 62.6; gender: M; tissue: rectal tumor; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.33; death due to tumor: 0; survival time (month): 143.54
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7e2f116b517395df9a328d803602c4f0f9cae50ac73aec8c10869a3401adb2b3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 184 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 184; age: 60.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 40.01; death due to tumor: 1; survival time (month): 73.94
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325421
sample_title: Patient 184 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 184; age: 60.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 40.01; death due to tumor: 1; survival time (month): 73.94
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fa880f9a44f2b21f78da208520bd017c7c1f779d8c1c181977f0b299a37c37ff
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 185 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 185; age: 72; gender: M; tissue: rectal tumor; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 120.26; death due to tumor: 0; survival time (month): 120.26
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325422
sample_title: Patient 185 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 185; age: 72; gender: M; tissue: rectal tumor; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 120.26; death due to tumor: 0; survival time (month): 120.26
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fc1316d0fc58c81e73e1579f014bc5ecd5a7bdc2ec98b5ae7ca3fc73d1db84c9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 186 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 186; age: 70.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 89.92; death due to tumor: 0; survival time (month): 89.92
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325423
sample_title: Patient 186 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 186; age: 70.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 89.92; death due to tumor: 0; survival time (month): 89.92
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8f94903fce6c8c8d2809502153beff92e56afb243413dde700c4ef94344580bb
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 187 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 187; age: 67.5; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 84.13; death due to tumor: 0; survival time (month): 84.13
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325424
sample_title: Patient 187 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 187; age: 67.5; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 84.13; death due to tumor: 0; survival time (month): 84.13
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f965adcc5249e227f0ebae61319471592a4a72fc54cfdb6f25bda16102b8e104
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 188 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 188; age: 70.5; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 10.75; death due to tumor: 1; survival time (month): 40.24
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325425
sample_title: Patient 188 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 188; age: 70.5; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 10.75; death due to tumor: 1; survival time (month): 40.24
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3307f1c06caeae9997ece0d54d2f97867aa2b09cdb0ed177267f56f2e4bd088a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 189 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 189; age: 61.5; gender: M; tissue: rectal tumor; kras mutation: Q61R; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 115.1; death due to tumor: 0; survival time (month): 115.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325426
sample_title: Patient 189 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 189; age: 61.5; gender: M; tissue: rectal tumor; kras mutation: Q61R; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 115.1; death due to tumor: 0; survival time (month): 115.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ab89d75eaa5fbad6635dc91e0b2f22fd01f4f584bdd07bd87ac0309b6116266b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 190 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 190; age: 53.8; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 77.23
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325427
sample_title: Patient 190 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 190; age: 53.8; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 77.23
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e4709c200729873c88eeda001341043ce6495316fddf017dc4e3b65710f1ac83
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 191 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 191; age: 36.2; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 8.32; death due to tumor: 1; survival time (month): 14.37
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325428
sample_title: Patient 191 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 191; age: 36.2; gender: F; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 8.32; death due to tumor: 1; survival time (month): 14.37
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f6fdfa823b6618bcba36de5d11f2f61d7adcade10401465cb39c850eea66ba12
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 192 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 192; age: 58.6; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.5; death due to tumor: 0; survival time (month): 86.5
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325429
sample_title: Patient 192 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 192; age: 58.6; gender: M; tissue: rectal tumor; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.5; death due to tumor: 0; survival time (month): 86.5
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 685cd5e2087066a63ca2cee69e9a4b5af37c85fc75c859ef733431a9467d0f2f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 193 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 193; age: 53.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 97.28; death due to tumor: 0; survival time (month): 97.28
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325430
sample_title: Patient 193 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 193; age: 53.8; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 97.28; death due to tumor: 0; survival time (month): 97.28
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4d95e7b1626b9129622ac22aefbbdfd3668c6faf4850d7095c7f67ef1fea5930
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 194 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 194; age: 61.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.22; death due to tumor: 0; survival time (month): 73.22
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325431
sample_title: Patient 194 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 194; age: 61.3; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.22; death due to tumor: 0; survival time (month): 73.22
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 00383995a99fbd945176f29777120644f298719fe1789fc22d2fec7997b3c4f9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 195 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 195; age: 54.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 4.83; death due to tumor: 0; survival time (month): 66.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325432
sample_title: Patient 195 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 195; age: 54.9; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 4.83; death due to tumor: 0; survival time (month): 66.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fe2f960c95c6edffebfa4a581d3a17e7dcc07b9a7ed3acca479bd04213c76bc9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 196 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 196; age: 63.6; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 69.34; death due to tumor: 0; survival time (month): 69.34
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325433
sample_title: Patient 196 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 196; age: 63.6; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 69.34; death due to tumor: 0; survival time (month): 69.34
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dd5554043aa29cd5aed38318b076254be51cd9d5f461909ee303a407b5997a81
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 197 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 197; age: 61.9; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.1; death due to tumor: 0; survival time (month): 86.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325434
sample_title: Patient 197 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 197; age: 61.9; gender: M; tissue: rectal tumor; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.1; death due to tumor: 0; survival time (month): 86.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: debd846085d18253586e47adccd715e1ea7332865812eaa596d91a583cce0896
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 198 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 198; age: 41.7; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 61.32
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325435
sample_title: Patient 198 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 198; age: 41.7; gender: M; tissue: rectal tumor; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 61.32
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e97e209958b992378887e5d6614af529edfaf319bafd91b756b815fa37cae3c2
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 199 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 199; age: 68.1; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 40.73
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325436
sample_title: Patient 199 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 199; age: 68.1; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 40.73
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2463636988cd12e2657e344d5cc1a6b665ede5a323808c4d2c5b63fa6f1c9a59
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 200 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 200; age: 67.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 3.48; death due to tumor: 0; survival time (month): 3.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325437
sample_title: Patient 200 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 200; age: 67.1; gender: F; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 3.48; death due to tumor: 0; survival time (month): 3.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 92cc8d7f2aeaccbc2c758921e17168fe0ebf13787e3e2adf0c52596d447504de
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 201 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 201; age: 72; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.64; death due to tumor: 0; survival time (month): 72.23
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325438
sample_title: Patient 201 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 201; age: 72; gender: M; tissue: rectal tumor; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.64; death due to tumor: 0; survival time (month): 72.23
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a4c2b61617207c5bf403c6f7cf5334f933fd81be9280291ac67e44906b8457aa
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 202 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 202; age: 66.8; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.09; death due to tumor: 0; survival time (month): 70.09
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325439
sample_title: Patient 202 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 202; age: 66.8; gender: M; tissue: rectal tumor; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.09; death due to tumor: 0; survival time (month): 70.09
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3292c41511c894387825ed9e1f72413ee53dc379870c55223ae3e4ca525441b5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 203 tumor sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Explicit sample label case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- rectal tumor
- Characteristics
- patient: Tum Patient 203; age: 69.4; gender: F; tissue: rectal tumor; kras mutation: K117N; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 71.77
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325440
sample_title: Patient 203 tumor sample
source_name: rectal tumor
characteristics: patient: Tum Patient 203; age: 69.4; gender: F; tissue: rectal tumor; kras mutation: K117N; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 71.77
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0de7a8deaa15e9cd909feedaa210465a8e889bfe9f86161d52b9f3b0aba58a4e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 1 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 1; age: 55.6; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -4.08; death due to tumor: 0; survival time (month): 41.92
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325441
sample_title: Patient 1 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 1; age: 55.6; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -4.08; death due to tumor: 0; survival time (month): 41.92
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 48cb082b875b6b93058953847040165e2cf3e0346aa4f9b0d1f78e4e5961f1d0
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 2 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 2; age: 65.6; gender: M; tissue: mucosa; kras mutation: I21L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.27; death due to tumor: 0; survival time (month): 40.27
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325442
sample_title: Patient 2 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 2; age: 65.6; gender: M; tissue: mucosa; kras mutation: I21L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.27; death due to tumor: 0; survival time (month): 40.27
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0a29f9fff7d442d69e53213a9b95a070e03a3606404dc4722ddd0e5345e34f64
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 3 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 3; age: 62.7; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.62; death due to tumor: 0; survival time (month): 29.62
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325443
sample_title: Patient 3 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 3; age: 62.7; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.62; death due to tumor: 0; survival time (month): 29.62
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d70d900bc532242383e868b0d3a747959737e4841548706cb202c89e3bba51f4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 4 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 4; age: 61.8; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.65; death due to tumor: 0; survival time (month): 32.65
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325444
sample_title: Patient 4 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 4; age: 61.8; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.65; death due to tumor: 0; survival time (month): 32.65
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cbcc98724092970605fb1b1a305771938486c41f9b3168b9ab6259716da2ac1d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 5 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 5; age: 52.1; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 31.59; death due to tumor: 0; survival time (month): 31.59
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325445
sample_title: Patient 5 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 5; age: 52.1; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 31.59; death due to tumor: 0; survival time (month): 31.59
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 597911efda838c486df35cecf4d9243ebf2c89f72b41968565f206d7afeb5abd
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 6 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 6; age: 59.1; gender: M; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.52; death due to tumor: 0; survival time (month): 34.52
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325446
sample_title: Patient 6 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 6; age: 59.1; gender: M; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.52; death due to tumor: 0; survival time (month): 34.52
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2b78ede5442a1485c6fdd2001426f3ac5fc4269e1247fc5c0fd420ae6645ec57
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 7 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 7; age: 70.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.68; death due to tumor: 0; survival time (month): 32.68
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325447
sample_title: Patient 7 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 7; age: 70.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 32.68; death due to tumor: 0; survival time (month): 32.68
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 89632974b7665481c664ec24314687b0f7c566e0c4cc0a6a920109debc21efec
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 8 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 8; age: 60.7; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 30.31; death due to tumor: 0; survival time (month): 30.31
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325448
sample_title: Patient 8 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 8; age: 60.7; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 30.31; death due to tumor: 0; survival time (month): 30.31
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e924d05c818065492b842cc4884b8efdc09688023dcf2bd8c3f916d6e4edce4b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 9 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 9; age: 55; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 28.08; death due to tumor: 0; survival time (month): 28.08
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325449
sample_title: Patient 9 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 9; age: 55; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 28.08; death due to tumor: 0; survival time (month): 28.08
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b2dc9851c070de89435709914c551a70a0653c24f70e65c508aa762ad077b49d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 10 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 10; age: 53.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 27.55; death due to tumor: 0; survival time (month): 27.55
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325450
sample_title: Patient 10 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 10; age: 53.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 27.55; death due to tumor: 0; survival time (month): 27.55
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ead47246f6ea6ee61126850bb58cd1cdac196e83f19b5216d07c0cb8699582f1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 11 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 11; age: NA; gender: M; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: NA; metastasis after rct: NA; cancer recurrance after surgery: 0; disease free time (month): NA; death due to tumor: 0; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325451
sample_title: Patient 11 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 11; age: NA; gender: M; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: NA; metastasis after rct: NA; cancer recurrance after surgery: 0; disease free time (month): NA; death due to tumor: 0; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b1b5b4942ede2abe199c084df9d61a9a901081bbf81ec1859ecd8e9d7299bf12
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 12 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 12; age: 58.6; gender: M; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 14.93; death due to tumor: 0; survival time (month): 14.93
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325452
sample_title: Patient 12 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 12; age: 58.6; gender: M; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 14.93; death due to tumor: 0; survival time (month): 14.93
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7fd0cb376cbef4d75cfa4dda13634711ed25490439985e96d93d2f70049d5d86
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 13 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 13; age: 68.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.38; death due to tumor: 0; survival time (month): 23.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325453
sample_title: Patient 13 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 13; age: 68.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.38; death due to tumor: 0; survival time (month): 23.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f28fbb3c18ad7cfac99d79208504bd133a82e8985ac310cfb3cf1cc2419224b4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 14 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 14; age: 58.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 6.71; death due to tumor: 0; survival time (month): 25.81
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325454
sample_title: Patient 14 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 14; age: 58.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 6.71; death due to tumor: 0; survival time (month): 25.81
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 34d1b911163a1d4a0920e6e7e57839acc21f91ce1d6c6ba721211a5a2aa01183
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 15 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 15; age: 70.1; gender: M; tissue: mucosa; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: NA; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325455
sample_title: Patient 15 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 15; age: 70.1; gender: M; tissue: mucosa; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: NA; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 75106ccd2bcc798ca01d457ef185bb1bef3101b901274b7154a24b5fbc7e15f3
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 16 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 16; age: 77.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.72; death due to tumor: 0; survival time (month): 34.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325456
sample_title: Patient 16 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 16; age: 77.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.72; death due to tumor: 0; survival time (month): 34.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: de69a8e8081ea1fb56b4ad9ee250140c82fd33c7cf23d96fe9c7d98078461e5b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 17 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 17; age: 68.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.63; death due to tumor: 0; survival time (month): 18.28
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325457
sample_title: Patient 17 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 17; age: 68.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.63; death due to tumor: 0; survival time (month): 18.28
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4c5c3b393e7a7171ce3b609a22b044281c30e7eada00210bdbbf570229c7f6e4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 18 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 18; age: 75.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.32; death due to tumor: 1; survival time (month): 10.26
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325458
sample_title: Patient 18 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 18; age: 75.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.32; death due to tumor: 1; survival time (month): 10.26
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 64ebaa4c1cbf19b7c06875ce59625965b95d357c1fbed0ba0f4f84b0eff71461
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 19 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 19; age: 76.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 10.62; death due to tumor: 0; survival time (month): 10.62
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325459
sample_title: Patient 19 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 19; age: 76.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: NA; metastasis before rct: NA; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 10.62; death due to tumor: 0; survival time (month): 10.62
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 690b665824d3fe5613347dcb048c15362f18299a02f6e6d0adbda01f9c0d64ba
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 20 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 20; age: 38.2; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.25; death due to tumor: 0; survival time (month): 8.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325460
sample_title: Patient 20 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 20; age: 38.2; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.25; death due to tumor: 0; survival time (month): 8.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: efef6cd0f9e1d3b34d991bdcedccbb289c9fe269c6c02bef688426ae36e8a563
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 21 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 21; age: 61.1; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -0.62; death due to tumor: 1; survival time (month): 5.75
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325461
sample_title: Patient 21 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 21; age: 61.1; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -0.62; death due to tumor: 1; survival time (month): 5.75
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6c23e237c8e0679d05ce3956cded5ff09f2c4c6d7f3bd32e43026a7f6562f7b2
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 22 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 22; age: 69.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.28; death due to tumor: 0; survival time (month): 23.28
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325462
sample_title: Patient 22 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 22; age: 69.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.28; death due to tumor: 0; survival time (month): 23.28
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e7777ef4388aa0bb125227fa301c36032bff7d7ceee08b340feb309361ee2bfb
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 23 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 23; age: 54.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.8; death due to tumor: 0; survival time (month): 23.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325463
sample_title: Patient 23 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 23; age: 54.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.8; death due to tumor: 0; survival time (month): 23.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6dc1b95d7edac50a2b255224886528fc1e37f18538d1c7f1314c15b735dc3299
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 24 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 24; age: 57.4; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.33; death due to tumor: 0; survival time (month): 7.33
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325464
sample_title: Patient 24 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 24; age: 57.4; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 7.33; death due to tumor: 0; survival time (month): 7.33
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2720c1f6f8412320d10b6b63d91435c62d1433eec9880efd885775581c593475
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 25 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 25; age: 61.3; gender: M; tissue: mucosa; kras mutation: Q61P; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 15.25; death due to tumor: 0; survival time (month): 24.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325465
sample_title: Patient 25 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 25; age: 61.3; gender: M; tissue: mucosa; kras mutation: Q61P; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 15.25; death due to tumor: 0; survival time (month): 24.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b7061887e4135ce8055070e1d698599e020d08683c306d242f0f6d68bf2fd0c5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 26 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 26; age: 47; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.55; death due to tumor: 0; survival time (month): 22.55
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325466
sample_title: Patient 26 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 26; age: 47; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.55; death due to tumor: 0; survival time (month): 22.55
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dd6fca6910cb8710333a7f70b7320560a946f864b93adeb7dab84fd9c9ab590c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 27 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 27; age: 62.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.22; death due to tumor: 0; survival time (month): 22.22
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325467
sample_title: Patient 27 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 27; age: 62.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 22.22; death due to tumor: 0; survival time (month): 22.22
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6f70066f069284bbbbc5b55a817e05a59c6e1de913ab1302b21ff3e1043f7432
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 28 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 28; age: 51.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 17.98; death due to tumor: 0; survival time (month): 17.98
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325468
sample_title: Patient 28 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 28; age: 51.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 17.98; death due to tumor: 0; survival time (month): 17.98
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b20e8a17dc9cc56bc659be2a19f25b9be343ca0ede0b59a0d7e391584c5846db
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 29 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 29; age: 73.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 6.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325469
sample_title: Patient 29 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 29; age: 73.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 6.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ef3f6d3760f36c2e36cfb716b0df5732b74b4d7cb5d02d2a4cd69565abf89aa1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 30 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 30; age: 47.2; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.99; death due to tumor: 0; survival time (month): 13.12
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325470
sample_title: Patient 30 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 30; age: 47.2; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -2.99; death due to tumor: 0; survival time (month): 13.12
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8a82ffc7a96aeadece455999b6770e0af3e606b6e90cf4502b272e5ccc56944c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 31 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 31; age: 72.7; gender: F; tissue: mucosa; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 16.21; death due to tumor: 0; survival time (month): 16.21
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325471
sample_title: Patient 31 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 31; age: 72.7; gender: F; tissue: mucosa; kras mutation: G12S; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 16.21; death due to tumor: 0; survival time (month): 16.21
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 259c50407119e3f90ec2a04462032f8dd3e05b76709599b1f18c1fbbd66570aa
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 32 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 32; age: 38.8; gender: M; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 6.38; death due to tumor: 0; survival time (month): 6.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325472
sample_title: Patient 32 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 32; age: 38.8; gender: M; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 6.38; death due to tumor: 0; survival time (month): 6.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 96b8954e24483e344f2d607a50fcee4e1e8d9f49356fc858b491c51f41d8ed56
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 33 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 33; age: 75.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325473
sample_title: Patient 33 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 33; age: 75.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.02; death due to tumor: 0; survival time (month): 13.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d656e661542c284bc47178c921051e2fcc1cec69cbb3c6768da057a86d93147c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 34 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 34; age: 80; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.96; death due to tumor: 0; survival time (month): 2.96
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325474
sample_title: Patient 34 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 34; age: 80; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.96; death due to tumor: 0; survival time (month): 2.96
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: b1e028f9e194b1bbb051553bc38612948b6f1fd78d1996da12c1bdca00a48ffc
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 35 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 35; age: 60.9; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.05; death due to tumor: 0; survival time (month): 13.05
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325475
sample_title: Patient 35 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 35; age: 60.9; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 13.05; death due to tumor: 0; survival time (month): 13.05
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8e9eb9f2aea50c958a652ddff99adba765fc84b34e4b92f60c0146474f21fcfb
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 36 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 36; age: 76.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.74; death due to tumor: 0; survival time (month): 1.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325476
sample_title: Patient 36 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 36; age: 76.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.74; death due to tumor: 0; survival time (month): 1.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1b29b68f529a6817ed23b2efa35e47e7294b6a10101b717c6c06ae9f3188f298
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 37 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 37; age: 49.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 12.59; death due to tumor: 0; survival time (month): 12.59
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325477
sample_title: Patient 37 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 37; age: 49.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 12.59; death due to tumor: 0; survival time (month): 12.59
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d935e827721b4ee2c3dd2cd85b0d33d0c9ad5a4972e2096b76a449ebe90f0140
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 38 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 38; age: 49.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 11.57; death due to tumor: 0; survival time (month): 11.57
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325478
sample_title: Patient 38 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 38; age: 49.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 11.57; death due to tumor: 0; survival time (month): 11.57
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a0151fafca07e267e66274c7ab83f16f95ec0023449dfc69f4b370ceb9590829
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 39 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 39; age: 57.6; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 9.83; death due to tumor: 0; survival time (month): 9.83
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325479
sample_title: Patient 39 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 39; age: 57.6; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 9.83; death due to tumor: 0; survival time (month): 9.83
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 012c75d83c50768698ef293b1932ae6e91fa021fb2ddb152fdddf95cb86954a9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 40 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 40; age: 77.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.28; death due to tumor: 0; survival time (month): 8.28
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325480
sample_title: Patient 40 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 40; age: 77.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 8.28; death due to tumor: 0; survival time (month): 8.28
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 75c2c30077ac04ace83010d885331a43a7ba79419fd81d178e3bc0e233db4888
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 41 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 41; age: 72.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 22.68; death due to tumor: 0; survival time (month): 22.68
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325481
sample_title: Patient 41 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 41; age: 72.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 22.68; death due to tumor: 0; survival time (month): 22.68
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1a3625c1cfafb408341ba9f6c06385a32079e963c846f0be0c6b8a0b1863baa5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 42 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 42; age: 76.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 20.19; death due to tumor: 0; survival time (month): 20.19
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325482
sample_title: Patient 42 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 42; age: 76.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 20.19; death due to tumor: 0; survival time (month): 20.19
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 677f3acc48b4a2e6152ad5b431b5a3d508d9e9384e8ea7ca59e0db9d2a47411d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 43 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 43; age: 61.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325483
sample_title: Patient 43 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 43; age: 61.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: da6fab03d94117ec833f431ba281dbcd0977220ca3cf15970722e19fd7d6dd5c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 44 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 44; age: 66.3; gender: F; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325484
sample_title: Patient 44 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 44; age: 66.3; gender: F; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f854720de771244a68cf1341ece02622c8c93944213fe32fed72b884f7e62e4f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 45 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 45; age: 65.6; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325485
sample_title: Patient 45 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 45; age: 65.6; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0; death due to tumor: 0; survival time (month): 0
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fce8cc41251dea092f6024fdbce8fef57e935c8b431ae8ff2506904e4a8124af
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 46 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 46; age: 68.4; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325486
sample_title: Patient 46 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 46; age: 68.4; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: bb264b61356559f51ccc2295a408ff0549a96ec225e44f530e2633ba24a8b4bd
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 47 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 47; age: 78.9; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 0; metastasis before rct: NA; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325487
sample_title: Patient 47 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 47; age: 78.9; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 0; metastasis before rct: NA; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ac361838e90d0131da73e33f2b6420d0ce2277d900bc2505e4ea2324bd434064
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 48 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 48; age: 65.8; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325488
sample_title: Patient 48 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 48; age: 65.8; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3bd551bd48d03552da53e9e68a3210bb1ca8ea1584fa9a2bdc1ad1d3b52074a1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 49 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 49; age: 57.1; gender: F; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325489
sample_title: Patient 49 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 49; age: 57.1; gender: F; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: NA; disease free time (month): NA; death due to tumor: NA; survival time (month): NA
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 5f8b8ddf943ee1a62641286e5471646e74198a9be46f35fb19710d1bb2b0a508
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 50 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 50; age: 74.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.03; death due to tumor: 0; survival time (month): 29.03
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325490
sample_title: Patient 50 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 50; age: 74.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.03; death due to tumor: 0; survival time (month): 29.03
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 28f6f949f4b0d02d6565f6f813cf47f48ac5036657de1f1132b43c65418eff6a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 51 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 51; age: 48.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.78; death due to tumor: 0; survival time (month): 1.78
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325491
sample_title: Patient 51 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 51; age: 48.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 1.78; death due to tumor: 0; survival time (month): 1.78
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1618a67fc799529d74e05e48c0979677346ceb9e9f123eed4f50b5dcd9e4dbf6
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 52 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 52; age: 56.3; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0.69; death due to tumor: 0; survival time (month): 0.69
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325492
sample_title: Patient 52 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 52; age: 56.3; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 0.69; death due to tumor: 0; survival time (month): 0.69
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 12f239f7a9889333fdf51ec96308c92ae05debdbf1a8f5577274ade35e314b9b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 53 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 53; age: 61.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 151.17; death due to tumor: 0; survival time (month): 151.17
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325493
sample_title: Patient 53 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 53; age: 61.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 151.17; death due to tumor: 0; survival time (month): 151.17
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cdae7e5f5cd9216696e6f5bb569f79048ea016e13a8f5cf4c8e5d5c6bc57628b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 54 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 54; age: 65.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91; death due to tumor: 0; survival time (month): 91
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325494
sample_title: Patient 54 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 54; age: 65.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91; death due to tumor: 0; survival time (month): 91
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f106f472080720fd27038730e583a292902659767409caff3da85019d6b5a6ad
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 55 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 55; age: 49.2; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 144.3; death due to tumor: 0; survival time (month): 144.3
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325495
sample_title: Patient 55 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 55; age: 49.2; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 144.3; death due to tumor: 0; survival time (month): 144.3
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 961c4a1ea2aa452947e09d66dad882d07a42022a4f080742f9a9409bbcfb7b3c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 56 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 56; age: 63.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.01; death due to tumor: 0; survival time (month): 112.01
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325496
sample_title: Patient 56 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 56; age: 63.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.01; death due to tumor: 0; survival time (month): 112.01
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: faed6bfd7154ae59cc43f10fea0e0b1442cc3b7ee8de575576139c262dc32934
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 57 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 57; age: 58.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 111.25; death due to tumor: 0; survival time (month): 111.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325497
sample_title: Patient 57 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 57; age: 58.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 111.25; death due to tumor: 0; survival time (month): 111.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 66a600be4530edd5ca9916c4f78ba8e42e9b3b76e19d991a5929974564ea80a2
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 58 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 58; age: 66.4; gender: M; tissue: mucosa; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.04; death due to tumor: 0; survival time (month): 100.04
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325498
sample_title: Patient 58 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 58; age: 66.4; gender: M; tissue: mucosa; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.04; death due to tumor: 0; survival time (month): 100.04
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d4da7b2031a9ef2be224320e26dc7b5a16781c61f25d4fc22dbd412284fa10db
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 59 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 59; age: 62.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 3.16; death due to tumor: 0; survival time (month): 3.16
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325499
sample_title: Patient 59 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 59; age: 62.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 3.16; death due to tumor: 0; survival time (month): 3.16
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0d15b843e4b4faf1aff9458a4959b721425e3edff8e4bdde9a1feb16bcff2ed8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 60 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 60; age: 57.4; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.13; death due to tumor: 1; survival time (month): 70.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325500
sample_title: Patient 60 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 60; age: 57.4; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 29.13; death due to tumor: 1; survival time (month): 70.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: c5065f479dedd6a85caea3e6baa3a609e182781213ecb502edfdf2a8a968e7e1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 61 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 61; age: 48.4; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.24; death due to tumor: 0; survival time (month): 112.24
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325501
sample_title: Patient 61 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 61; age: 48.4; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 112.24; death due to tumor: 0; survival time (month): 112.24
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2ef854934f9aaf52a582b223dba5f12e325fb0376f1c85ba841491c002958b46
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 62 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 62; age: 71.2; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.53; death due to tumor: 0; survival time (month): 79.53
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325502
sample_title: Patient 62 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 62; age: 71.2; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.53; death due to tumor: 0; survival time (month): 79.53
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: de6e15dd62acf31cee54e6e3c453ab75cee8c49c267fb2995abd91f66a598f2a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 63 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 63; age: 71.2; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.84; death due to tumor: 0; survival time (month): 109.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325503
sample_title: Patient 63 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 63; age: 71.2; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.84; death due to tumor: 0; survival time (month): 109.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ea8db1b40d6ab9c14f5a485f0f97f5ee5a5341b6e52acc24ff7f1852a5666a9c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 64 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 64; age: 52.7; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 62.93; death due to tumor: 1; survival time (month): 110.17
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325504
sample_title: Patient 64 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 64; age: 52.7; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 62.93; death due to tumor: 1; survival time (month): 110.17
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8b60c7eac0524b160e6489c878dee1a53818304019d7ff5bcea09bf4a7900fe8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 65 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 65; age: 70.3; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 45.73; death due to tumor: 0; survival time (month): 45.73
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325505
sample_title: Patient 65 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 65; age: 70.3; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 45.73; death due to tumor: 0; survival time (month): 45.73
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 805e3c43618889912198e6b839beb4f41106aceab8eaf49b7f03d798f917641f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 66 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 66; age: 54; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 114.35; death due to tumor: 0; survival time (month): 114.35
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325506
sample_title: Patient 66 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 66; age: 54; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 114.35; death due to tumor: 0; survival time (month): 114.35
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 272e2e38ce72d111bc6782bb363fa40a7fc5ada09de434774c5001ab8b698cfd
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 67 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 67; age: 53.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 58.92; death due to tumor: 1; survival time (month): 84.36
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325507
sample_title: Patient 67 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 67; age: 53.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 58.92; death due to tumor: 1; survival time (month): 84.36
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: bd15877b3d1763c5abba3ec0b99d452230ea44d07ccf64f03391c64121e5e636
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 68 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 68; age: 60; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.79; death due to tumor: 0; survival time (month): 86.79
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325508
sample_title: Patient 68 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 68; age: 60; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 86.79; death due to tumor: 0; survival time (month): 86.79
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7e49b994d21e6616dcc9246df2fb599184fab3ae395fb7ccad155c14384674ee
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 69 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 69; age: 68.2; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 93.96; death due to tumor: 0; survival time (month): 93.96
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325509
sample_title: Patient 69 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 69; age: 68.2; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 93.96; death due to tumor: 0; survival time (month): 93.96
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 44cf8faeab9f01d93d3ff90363b51da230a30eb209e77e5bdae73477ab76104a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 70 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 70; age: 65.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 25.38; death due to tumor: 1; survival time (month): 51.52
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325510
sample_title: Patient 70 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 70; age: 65.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 25.38; death due to tumor: 1; survival time (month): 51.52
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 8315999c8f951ba0143d8fc07b377989138c3f696dbf852bfd72aedb73be3f78
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 71 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 71; age: 79.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.27; death due to tumor: 0; survival time (month): 88.27
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325511
sample_title: Patient 71 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 71; age: 79.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.27; death due to tumor: 0; survival time (month): 88.27
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6631c0652ac6772ebf58f97062cd87cb9ad9a2f6a999cf16168cb27bb99d0ea2
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 72 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 72; age: 81.4; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.98; death due to tumor: 0; survival time (month): 82.98
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325512
sample_title: Patient 72 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 72; age: 81.4; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.98; death due to tumor: 0; survival time (month): 82.98
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 929332a251528552de20c8270a2ee7b2377c8f6fe37f767acff882d65ee1b03e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 73 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 73; age: 66.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.31; death due to tumor: 0; survival time (month): 71.31
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325513
sample_title: Patient 73 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 73; age: 66.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.31; death due to tumor: 0; survival time (month): 71.31
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6ee769edc15a6ea2b1d15b81ade84893590050cd1110263adc289c1b355d5df0
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 74 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 74; age: 59.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 61.25; death due to tumor: 0; survival time (month): 61.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325514
sample_title: Patient 74 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 74; age: 59.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 61.25; death due to tumor: 0; survival time (month): 61.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 037efda4226c384931eff95f8698fc593c6f15de50196ed060585f337ccf42f1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 75 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 75; age: 57.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 83.97; death due to tumor: 0; survival time (month): 83.97
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325515
sample_title: Patient 75 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 75; age: 57.4; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 83.97; death due to tumor: 0; survival time (month): 83.97
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 060da08d09084700e35efaa61c0cd51f5a35394eada6b97aa3e6f3349db21a91
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 76 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 76; age: 81.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 39.25; death due to tumor: 0; survival time (month): 39.25
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325516
sample_title: Patient 76 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 76; age: 81.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 39.25; death due to tumor: 0; survival time (month): 39.25
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 256dcb67f13410214061ba947229e688d36f98a06a5371ea23e9ccc5a6199429
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 77 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 77; age: 62.3; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.39; death due to tumor: 0; survival time (month): 34.39
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325517
sample_title: Patient 77 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 77; age: 62.3; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 34.39; death due to tumor: 0; survival time (month): 34.39
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e946304d5120b124bcab1b4fbeb897fa355296a4b07d3d1ccf8e70aa3c13bdc4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 78 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 78; age: 63.7; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.83; death due to tumor: 0; survival time (month): 88.83
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325518
sample_title: Patient 78 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 78; age: 63.7; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 88.83; death due to tumor: 0; survival time (month): 88.83
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: c82585a863d8b5dee210f8e3644c053e43fa7986a3f41c4088ee36a4742fcc6b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 79 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 79; age: 66.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.63; death due to tumor: 0; survival time (month): 79.63
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325519
sample_title: Patient 79 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 79; age: 66.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.63; death due to tumor: 0; survival time (month): 79.63
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ae89953b1ebc32a0435556c6cb1f88175c1b66638be208cb56f14cee2fdf1c88
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 80 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 80; age: 71.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 73.48; death due to tumor: 0; survival time (month): 82.82
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325520
sample_title: Patient 80 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 80; age: 71.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 73.48; death due to tumor: 0; survival time (month): 82.82
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 907b655396a875300f61c5b830aa406786f7380ee80b7b9435ec553f9dea8743
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 81 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 81; age: 76.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.85; death due to tumor: 0; survival time (month): 77.85
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325521
sample_title: Patient 81 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 81; age: 76.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.85; death due to tumor: 0; survival time (month): 77.85
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a02c57451212d7ddf5c949b84c5f9f632d16b7b357f37e0b46ce9bfe3b3d7e88
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 82 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 82; age: 76.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.48; death due to tumor: 0; survival time (month): 75.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325522
sample_title: Patient 82 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 82; age: 76.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.48; death due to tumor: 0; survival time (month): 75.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f0cd135600b9acfed63b7d916a31cd20c95afc79b394e6197ab31eaeb50bdd1d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 83 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 83; age: 58.3; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.03; death due to tumor: 0; survival time (month): 96.03
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325523
sample_title: Patient 83 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 83; age: 58.3; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.03; death due to tumor: 0; survival time (month): 96.03
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: dc3b9cf74c70077cebb100ef04500185f6fff5df5e33477f684233b16138a986
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 84 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 84; age: 76.7; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 98.7; death due to tumor: 0; survival time (month): 98.7
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325524
sample_title: Patient 84 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 84; age: 76.7; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 98.7; death due to tumor: 0; survival time (month): 98.7
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 24a014eb9d7249aea03a92b0144428f6ad7acff97e06026c29dceb9e385f86f6
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 85 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 85; age: 62.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 34.06; death due to tumor: 1; survival time (month): 79.5
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325525
sample_title: Patient 85 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 85; age: 62.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 34.06; death due to tumor: 1; survival time (month): 79.5
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 38f37b20883c7cccd3b7180cd1e2bae8accba31f0ed32cabe058ef078c6bf48a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 86 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 86; age: 51.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 76.87; death due to tumor: 0; survival time (month): 76.87
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325526
sample_title: Patient 86 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 86; age: 51.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 76.87; death due to tumor: 0; survival time (month): 76.87
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 5ba55c26dc26eac89e46cdca696bffaafa1b822089b90f4341131eba3195ed70
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 87 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 87; age: 67.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.82; death due to tumor: 0; survival time (month): 29.82
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325527
sample_title: Patient 87 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 87; age: 67.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 29.82; death due to tumor: 0; survival time (month): 29.82
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 10d41fb05f9942280f5bff9f5ddd8704bc5b3bfd29cef4e5ae87118eb85139dd
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 88 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 88; age: 63.4; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 90.02; death due to tumor: 0; survival time (month): 90.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325528
sample_title: Patient 88 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 88; age: 63.4; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 90.02; death due to tumor: 0; survival time (month): 90.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 04605a14b5fd6cb35ab97abeef65d1e91adaf72f42fb16975d3a5f50c3c8146e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 89 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 89; age: 76.3; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.61; death due to tumor: 0; survival time (month): 71.61
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325529
sample_title: Patient 89 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 89; age: 76.3; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.61; death due to tumor: 0; survival time (month): 71.61
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a02cd162b3b51a06bb3ee8d0f41b135e574c3ded6bede2ed5f7da00decda080f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 90 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 90; age: 41.8; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 94.26; death due to tumor: 0; survival time (month): 94.26
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325530
sample_title: Patient 90 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 90; age: 41.8; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 94.26; death due to tumor: 0; survival time (month): 94.26
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cfc6db42383efa25d5e9d99a63b80173849004499235c084f8aaec7711c134ed
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 91 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 91; age: 58.1; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.63; death due to tumor: 0; survival time (month): 91.63
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325531
sample_title: Patient 91 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 91; age: 58.1; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.63; death due to tumor: 0; survival time (month): 91.63
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ea91d360a34899ee59b8347c97a8938bc745d2f194ffabb3bb538e31e387aeb6
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 92 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 92; age: 65.8; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.79; death due to tumor: 0; survival time (month): 60.79
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325532
sample_title: Patient 92 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 92; age: 65.8; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.79; death due to tumor: 0; survival time (month): 60.79
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: c39d4a40c546ce35d8231d3a01e1c92b769ffae2bc327259269684f3e56c87f5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 93 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 93; age: 59.5; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.52; death due to tumor: 0; survival time (month): 63.52
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325533
sample_title: Patient 93 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 93; age: 59.5; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.52; death due to tumor: 0; survival time (month): 63.52
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 30ec746f233f2f54f5a43881c8f517bc5dffcd642bd35822b3f9af6b6b7e801b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 94 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 94; age: 53.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.12; death due to tumor: 1; survival time (month): 33.6
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325534
sample_title: Patient 94 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 94; age: 53.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.12; death due to tumor: 1; survival time (month): 33.6
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 057e0b335e0bcdc86188378a03c903235564bc5f56682b76d692eda4d014f8c7
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 95 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 95; age: 56.9; gender: M; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 87.35; death due to tumor: 0; survival time (month): 87.35
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325535
sample_title: Patient 95 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 95; age: 56.9; gender: M; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 87.35; death due to tumor: 0; survival time (month): 87.35
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 758e60d3bf678135222949258ebdd3142ca8188cece87cc884834bba29ea6d24
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 96 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 96; age: 60.7; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.32; death due to tumor: 0; survival time (month): 109.32
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325536
sample_title: Patient 96 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 96; age: 60.7; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 109.32; death due to tumor: 0; survival time (month): 109.32
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 041f51543e2fb48c953fb24e918c809b063a02a8811fa7ebb2194db623dca072
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 97 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 97; age: 64.1; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 46.62; death due to tumor: 1; survival time (month): 73.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325537
sample_title: Patient 97 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 97; age: 64.1; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 46.62; death due to tumor: 1; survival time (month): 73.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: d2d54a571ab48edd595458bac7ffc38bdf00a50655a319837737631378cf3aaf
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 98 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 98; age: 55.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.78; death due to tumor: 1; survival time (month): 25.51
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325538
sample_title: Patient 98 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 98; age: 55.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.78; death due to tumor: 1; survival time (month): 25.51
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6f9b8b8377adbe41ea5271b8bca50e36310ac178184bb45f413349aa1f3e65cc
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 99 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 99; age: 50; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.62; death due to tumor: 0; survival time (month): 105.14
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325539
sample_title: Patient 99 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 99; age: 50; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.62; death due to tumor: 0; survival time (month): 105.14
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: eeb9ec174eb39aee771584f981ae9bde143014d5df9dd2fdcaa5deeab459ccf5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 100 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 100; age: 35.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 68.65; death due to tumor: 1; survival time (month): 91.53
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325540
sample_title: Patient 100 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 100; age: 35.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 68.65; death due to tumor: 1; survival time (month): 91.53
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2441f70fbca3d5b034706a3c4506615628e25b9aa95261851e16ad515757081c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 101 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 101; age: 77.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.13; death due to tumor: 0; survival time (month): 91.13
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325541
sample_title: Patient 101 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 101; age: 77.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 91.13; death due to tumor: 0; survival time (month): 91.13
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 725db3bd31a93270c696265f4f2db39ec4770b696189e1cbbd6130e6ea35d2ce
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 102 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 102; age: 65.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.79; death due to tumor: 0; survival time (month): 79.79
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325542
sample_title: Patient 102 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 102; age: 65.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 79.79; death due to tumor: 0; survival time (month): 79.79
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: bf19f6cd1ea90e970e93711b2ae48c18c8709c6858a67cd1f6423bd16d36d91d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 103 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 103; age: 74.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.64; death due to tumor: 1; survival time (month): 24.39
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325543
sample_title: Patient 103 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 103; age: 74.6; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.64; death due to tumor: 1; survival time (month): 24.39
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f9f5c4d210dbd62cd7560aaf8adb112861d196a054980895b69a17a39d0a688e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 104 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 104; age: 63; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.7; death due to tumor: 0; survival time (month): 100.7
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325544
sample_title: Patient 104 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 104; age: 63; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 100.7; death due to tumor: 0; survival time (month): 100.7
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ce113d34c66d3e941c255ebcf9e6151e82434a13b796dcf2b5d8bbfd00636f65
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 105 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 105; age: 73.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 85.84; death due to tumor: 0; survival time (month): 85.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325545
sample_title: Patient 105 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 105; age: 73.3; gender: M; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 85.84; death due to tumor: 0; survival time (month): 85.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e6fa651a70865da0f2f5e534ec68ad10434813f9ee0e81966c1511e28dfa43a8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 106 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 106; age: 73.3; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.72; death due to tumor: 0; survival time (month): 75.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325546
sample_title: Patient 106 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 106; age: 73.3; gender: M; tissue: mucosa; kras mutation: G12A; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 75.72; death due to tumor: 0; survival time (month): 75.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 3d086a51955444e947612e7eeafc301038f645605d081d0f0219c41a26440b84
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 107 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 107; age: 54.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.11; death due to tumor: 0; survival time (month): 78.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325547
sample_title: Patient 107 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 107; age: 54.8; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.11; death due to tumor: 0; survival time (month): 78.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 125ed87067b9b6ee9474375ec688a44ab5590ee8235a2793d813b5a02fb12e7f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 108 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 108; age: 61.5; gender: M; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.4; death due to tumor: 0; survival time (month): 2.4
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325548
sample_title: Patient 108 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 108; age: 61.5; gender: M; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.4; death due to tumor: 0; survival time (month): 2.4
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 82d8c13d0d8af16e816df35eb86e6e0027bad0ca4e323c876ed02e58d49dc82e
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 109 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 109; age: 63.2; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 14.99; death due to tumor: 1; survival time (month): 29.46
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325549
sample_title: Patient 109 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 109; age: 63.2; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 14.99; death due to tumor: 1; survival time (month): 29.46
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ca84876c0a32e79b65a68cd4e460e5022dfb5e60639cfcf7942c0eb126008adb
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 110 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 110; age: 63.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.05; death due to tumor: 0; survival time (month): 23.05
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325550
sample_title: Patient 110 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 110; age: 63.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 23.05; death due to tumor: 0; survival time (month): 23.05
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: aaecaf635c3fb1be0495304b772ba407e75e8489213aef5966e3cc41056540e8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 111 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 111; age: 75.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.82; death due to tumor: 1; survival time (month): 20.32
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325551
sample_title: Patient 111 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 111; age: 75.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 12.82; death due to tumor: 1; survival time (month): 20.32
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 68112daa68f416bb72963fda1f2ee4451ef1d0d3da91c3585ee8954fbd1d78b4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 112 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 112; age: 68.3; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 95.74; death due to tumor: 0; survival time (month): 95.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325552
sample_title: Patient 112 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 112; age: 68.3; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 95.74; death due to tumor: 0; survival time (month): 95.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fc9df58d30f41b1626ce550d7dd6038dd83131ad99e63f79726d4701ed10064c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 113 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 113; age: 51.1; gender: F; tissue: mucosa; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.18; death due to tumor: 0; survival time (month): 36.33
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325553
sample_title: Patient 113 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 113; age: 51.1; gender: F; tissue: mucosa; kras mutation: Q61L; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 18.18; death due to tumor: 0; survival time (month): 36.33
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 88ba34d945aaca69ad81c4813f7300940869e88d4213da9e32cfeb046757b7a4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 114 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 114; age: 46.3; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.13; death due to tumor: 0; survival time (month): 96.13
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325554
sample_title: Patient 114 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 114; age: 46.3; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 96.13; death due to tumor: 0; survival time (month): 96.13
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f59a6e73cca3926239c17c2ad1df01dba296427b32961ef386c851fc121ba2ef
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 115 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 115; age: 59.4; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325555
sample_title: Patient 115 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 115; age: 59.4; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ffbc793ddf26cd781ff0415daecfd83f0d7967a4eebed5358a16dfba20d848a5
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 116 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 116; age: 70.9; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.14; death due to tumor: 0; survival time (month): 45.57
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325556
sample_title: Patient 116 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 116; age: 70.9; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 33.14; death due to tumor: 0; survival time (month): 45.57
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 27fcc7a1d94f7919007dd4ecfb511221e0f0b3203dcd498294e21daf53c69030
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 117 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 117; age: 59.8; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.87; death due to tumor: 0; survival time (month): 64.87
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325557
sample_title: Patient 117 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 117; age: 59.8; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.87; death due to tumor: 0; survival time (month): 64.87
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 99ceefa8ac6ceaafbeed017b511b8e6f168d32b4a7b3942dfbd3061e262e9676
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 118 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 118; age: 81.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 44.61; death due to tumor: 0; survival time (month): 44.61
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325558
sample_title: Patient 118 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 118; age: 81.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 44.61; death due to tumor: 0; survival time (month): 44.61
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 5bf87a122c1829b42576e25c133f9f369fcea55a784fe5e07b775b391f0cb80c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 119 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 119; age: 73; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.19; death due to tumor: 0; survival time (month): 70.19
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325559
sample_title: Patient 119 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 119; age: 73; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.19; death due to tumor: 0; survival time (month): 70.19
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e38eb55e72b6f70f4e1d69c7109efcadef9192458d2fdc0fccf282f989fb5565
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 120 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 120; age: 70.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.74; death due to tumor: 0; survival time (month): 71.74
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325560
sample_title: Patient 120 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 120; age: 70.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.74; death due to tumor: 0; survival time (month): 71.74
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6226891de3c2c6ea7b35244e95d8bd26f03d2e6c2c1cb202c3316455792645f0
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 121 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 121; age: 63.8; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.99; death due to tumor: 1; survival time (month): 49.91
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325561
sample_title: Patient 121 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 121; age: 63.8; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.99; death due to tumor: 1; survival time (month): 49.91
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f872c91b19a9f0e1b41d04b34341682efb9c19825bb50e9d1a5dcae9816d0b7c
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 122 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 122; age: 63.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.42; death due to tumor: 0; survival time (month): 63.42
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325562
sample_title: Patient 122 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 122; age: 63.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.42; death due to tumor: 0; survival time (month): 63.42
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 4cce8bccde1811fe4f0f8bb544b0959021a89a3ee5ee52a5fae9f22b115d13ad
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 123 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 123; age: 72.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 91.43
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325563
sample_title: Patient 123 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 123; age: 72.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 0; survival time (month): 91.43
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ef213afe9fa00f7c37e94021ea3270aaeb0c67438289afbe8ec3584a4e42fdca
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 124 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 124; age: 51.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.19; death due to tumor: 1; survival time (month): 8.81
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325564
sample_title: Patient 124 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 124; age: 51.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): -3.19; death due to tumor: 1; survival time (month): 8.81
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: fbf5518a17fff0cdd31538374ae80e9c78172f10c5e5285f119989a50268dfdb
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 125 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 125; age: 69.6; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.72; death due to tumor: 0; survival time (month): 63.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325565
sample_title: Patient 125 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 125; age: 69.6; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.72; death due to tumor: 0; survival time (month): 63.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0e38b8c173352b30b0729c90c5474f70181f50f61bcecce26f4b1be24cc69846
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 126 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 126; age: 65.1; gender: F; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.53; death due to tumor: 0; survival time (month): 60.53
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325566
sample_title: Patient 126 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 126; age: 65.1; gender: F; tissue: mucosa; kras mutation: G12C; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 4; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.53; death due to tumor: 0; survival time (month): 60.53
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6a780b0c535d2483cc18f7e7b6aabf111ae5de9b6bea660505924ca135eaaca9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 127 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 127; age: 60.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.84; death due to tumor: 0; survival time (month): 73.84
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325567
sample_title: Patient 127 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 127; age: 60.2; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.84; death due to tumor: 0; survival time (month): 73.84
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e283b2113c5dd4d1172a537fb3fc9156a739821dbefc8b81487ab7050286bb5d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 128 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 128; age: 56.3; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 65.72; death due to tumor: 0; survival time (month): 65.72
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325568
sample_title: Patient 128 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 128; age: 56.3; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 65.72; death due to tumor: 0; survival time (month): 65.72
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a78ffe348bd5b1a0154f035536d3abd5bfe6ca982546429f2e66e0716750d888
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 129 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 129; age: 66.2; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.46; death due to tumor: 0; survival time (month): 60.46
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325569
sample_title: Patient 129 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 129; age: 66.2; gender: M; tissue: mucosa; kras mutation: NA; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 60.46; death due to tumor: 0; survival time (month): 60.46
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: de49cf2ac214f3b7529d31ae2e20e813b5510b095dd46afa58a16f1f4e8585a0
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 130 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 130; age: 79.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325570
sample_title: Patient 130 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 130; age: 79.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 881c5b25344106deec8cae00d14b2c3c5a53d756d46eb20cd4012d228d6a2939
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 131 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 131; age: 67.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 68.48; death due to tumor: 0; survival time (month): 68.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325571
sample_title: Patient 131 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 131; age: 67.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 68.48; death due to tumor: 0; survival time (month): 68.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9ecc62c3eb38fa8607424a9f47c86a63db16fe1d2a1ffc621bef259a686f94e8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 132 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 132; age: 60.6; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.09; death due to tumor: 0; survival time (month): 63.09
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325572
sample_title: Patient 132 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 132; age: 60.6; gender: M; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.09; death due to tumor: 0; survival time (month): 63.09
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0be94db608e1aade8f4f9dcec59dae14aa35ee9f7ae154c562c9bb80664892ad
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 133 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 133; age: 51.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.24; death due to tumor: 0; survival time (month): 71.24
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325573
sample_title: Patient 133 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 133; age: 51.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.24; death due to tumor: 0; survival time (month): 71.24
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7e9f69d2c6f7c085b3867f3e6b5a9e89e6567560f136b1488b4670d96730dc32
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 134 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 134; age: 57.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 3.32
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325574
sample_title: Patient 134 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 134; age: 57.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + Cetuximab + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: NA; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 3.32
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e26e64d715594dfa448bcff4166bcf9150d4135f59c9e92f4c2ef53b8cd9b1e6
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 135 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 135; age: 54.8; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325575
sample_title: Patient 135 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 135; age: 54.8; gender: M; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.43; death due to tumor: 0; survival time (month): 72.43
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 152d45c31483728c7cfdfa0a3f6c89b9c6c4ae377e59af7358be685b996097e1
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 136 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 136; age: 73.7; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.13; death due to tumor: 0; survival time (month): 61.41
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325576
sample_title: Patient 136 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 136; age: 73.7; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 24.13; death due to tumor: 0; survival time (month): 61.41
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 68e4b87637044c14a52be8d76a66e44ed968bf42b5931d4f0849d8a903fb4823
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 137 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 137; age: 73.9; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 23.01; death due to tumor: 1; survival time (month): 42.97
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325577
sample_title: Patient 137 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 137; age: 73.9; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 23.01; death due to tumor: 1; survival time (month): 42.97
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ce83c6bd536ee608902b67228f130da4ca3df332f32190108f8b948abfb605c2
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 138 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 138; age: 50.5; gender: F; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 42.54; death due to tumor: 0; survival time (month): 42.54
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325578
sample_title: Patient 138 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 138; age: 50.5; gender: F; tissue: mucosa; kras mutation: A146T; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 42.54; death due to tumor: 0; survival time (month): 42.54
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9a5c0423ab0cac355ff4d85a0a1a8d23373925e13b2f1f984c7fb651db456ab9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 139 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 139; age: 77; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.88; death due to tumor: 0; survival time (month): 82.88
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325579
sample_title: Patient 139 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 139; age: 77; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 82.88; death due to tumor: 0; survival time (month): 82.88
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6af6e8172f3456f98cd257f908b26649a4091ce683f32e06c414a29070c99ac8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 140 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 140; age: 41.8; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.8; death due to tumor: 0; survival time (month): 71.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325580
sample_title: Patient 140 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 140; age: 41.8; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.8; death due to tumor: 0; survival time (month): 71.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ede53a2b98d49f9922dc5bd9abe60db9b86dc1094b68932a7eb64c20e9a06bcd
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 141 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 141; age: 73.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.48; death due to tumor: 0; survival time (month): 63.48
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325581
sample_title: Patient 141 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 141; age: 73.1; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 63.48; death due to tumor: 0; survival time (month): 63.48
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 0c20ade4d5a173e354b7dcce2eb6d2cd354c331d905d2e96d5fa505d61fe9c92
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 142 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 142; age: 67; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 78.71; death due to tumor: 0; survival time (month): 78.71
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325582
sample_title: Patient 142 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 142; age: 67; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 78.71; death due to tumor: 0; survival time (month): 78.71
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: cb48d1a3687d446e107f520abcfe1bfc4e58d5a0667d49391044a67aafecab5b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 143 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 143; age: 61.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325583
sample_title: Patient 143 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 143; age: 61.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 73.38; death due to tumor: 0; survival time (month): 73.38
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: e95e328bce9badc4a43733e472deae31211b091f14959e895c0d07991cd56b7a
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 144 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 144; age: 42; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.59; death due to tumor: 0; survival time (month): 77.59
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325584
sample_title: Patient 144 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 144; age: 42; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 77.59; death due to tumor: 0; survival time (month): 77.59
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1009acd4dd63a0b4440d78f37f962fd130ab5a6a8f6c1fefbb948df491cab00d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 145 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 145; age: 68.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.67; death due to tumor: 0; survival time (month): 40.67
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325585
sample_title: Patient 145 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 145; age: 68.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 40.67; death due to tumor: 0; survival time (month): 40.67
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 50175db1d8d477a81328ff68cb05841f838cbce4563fdc82cb1339356ba9a5ac
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 146 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 146; age: 59.4; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 35.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325586
sample_title: Patient 146 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 146; age: 59.4; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 1; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 1; cancer recurrance after surgery: 1; disease free time (month): 0; death due to tumor: 1; survival time (month): 35.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 9d8d0ae177520314b63a6c571182b350c082ca37b7b23a3f182f822fc5245bb8
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 147 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 147; age: 78.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.5; death due to tumor: 0; survival time (month): 64.5
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325587
sample_title: Patient 147 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 147; age: 78.8; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 64.5; death due to tumor: 0; survival time (month): 64.5
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 65063c411f449d52830ef5226640cc78d0b8fd19375bf1486eb2356c176a023d
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 148 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 148; age: 57.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.56; death due to tumor: 0; survival time (month): 72.56
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325588
sample_title: Patient 148 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 148; age: 57.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.56; death due to tumor: 0; survival time (month): 72.56
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: f9da543ec592d8321e3f436207cd93bd5c723f7fec242f3744c80f65c3c3988f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 149 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 149; age: 63.7; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 74.33; death due to tumor: 0; survival time (month): 74.33
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325589
sample_title: Patient 149 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 149; age: 63.7; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 74.33; death due to tumor: 0; survival time (month): 74.33
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 40609834b1848605c189501ced11c216e0eff088517be4e03e04faa23978673b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 150 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 150; age: 60.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.32; death due to tumor: 1; survival time (month): 40.83
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325590
sample_title: Patient 150 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 150; age: 60.7; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 27.32; death due to tumor: 1; survival time (month): 40.83
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 7d35cdec5dbc9209fae9ad729d5f3a10b1f19465750a51dd1c8d910f6c45596b
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 151 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 151; age: 62.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.1; death due to tumor: 0; survival time (month): 72.1
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325591
sample_title: Patient 151 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 151; age: 62.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.1; death due to tumor: 0; survival time (month): 72.1
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: c7fdafbb148198a88a3269eebb4d3e2cc256982bdb69a436dce1fe4f13bcdb11
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 152 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 152; age: 51.7; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 69.04; death due to tumor: 0; survival time (month): 69.04
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325592
sample_title: Patient 152 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 152; age: 51.7; gender: F; tissue: mucosa; kras mutation: G12V; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 69.04; death due to tumor: 0; survival time (month): 69.04
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 351f883ac049685c75cf85702058c2180609b0f3f7bf7f7c8d0012f1549b0eb7
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 153 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 153; age: 56.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.09; death due to tumor: 0; survival time (month): 70.09
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325593
sample_title: Patient 153 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 153; age: 56.5; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 70.09; death due to tumor: 0; survival time (month): 70.09
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: a1d607a04b9bc575fa5ce2f065095b7f519819e3302a1f86272407f3bc679814
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 154 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 154; age: 74.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.2; death due to tumor: 0; survival time (month): 2.2
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325594
sample_title: Patient 154 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 154; age: 74.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 2.2; death due to tumor: 0; survival time (month): 2.2
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: ae0fec92df0193c1f36fbc04963b537e7ab8e131eee68331d9e6b56b20dc00a4
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 155 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 155; age: 61.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.54; death due to tumor: 0; survival time (month): 71.54
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325595
sample_title: Patient 155 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 155; age: 61.5; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 2; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 2; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 71.54; death due to tumor: 0; survival time (month): 71.54
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 2a09d34ac0d99a1d8bd62d76487d23fddf1f638af11c836c120641610fbaac28
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 156 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 156; age: 69.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 67.76; death due to tumor: 0; survival time (month): 67.76
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325596
sample_title: Patient 156 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 156; age: 69.9; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 1; lymph node metastasis after rct: 1; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 67.76; death due to tumor: 0; survival time (month): 67.76
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 1f660d6b8458845f39b129b424ba2e7b5fcfec17a38eabcad802b8901c46eb21
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 157 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 157; age: 63.6; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.03; death due to tumor: 0; survival time (month): 72.03
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325597
sample_title: Patient 157 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 157; age: 63.6; gender: F; tissue: mucosa; kras mutation: G13D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 72.03; death due to tumor: 0; survival time (month): 72.03
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 5157ae48278c85b717c0c96905210fb6dc494000c0098ea8b07dae80b22d0d83
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 158 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 158; age: 59; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 8.45; death due to tumor: 1; survival time (month): 27.12
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325598
sample_title: Patient 158 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 158; age: 59; gender: F; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 1; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 1; disease free time (month): 8.45; death due to tumor: 1; survival time (month): 27.12
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 363555ff2c6a27be260d48bedde67f4e783a358890b0de60d25825aa70e6322f
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 159 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 159; age: 53.1; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 59.8; death due to tumor: 0; survival time (month): 59.8
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325599
sample_title: Patient 159 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 159; age: 53.1; gender: F; tissue: mucosa; kras mutation: G12D; preoperative radiochemotherapy (rct): 5-FU + Oxaliplatin + RT; depth of invasion before rct: 3; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 0; lymph node metastasis after rct: 0; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 59.8; death due to tumor: 0; survival time (month): 59.8
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 30f86ff092e7acb4c7b45d03bd9b25fbc9c78ff7883f933cf177d7e2c1044e38
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol
Patient 160 mucosa control sample
Excluded: at least one selected requirement is not met. assay type: bulk RNA-seq — Does not meet requirement. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Sample-local control marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Meets requirement
- Supported by the indexed evidence.
- organism_evidence_text: homo sapiens
-
assay type: bulk RNA-seq — Does not meet requirement
- The reported value differs from the selected requirement.
- assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visual...
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- mucosa
- Characteristics
- patient: Con Patient 160; age: 65.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 37.02; death due to tumor: 0; survival time (month): 37.02
- Description
- Not reported
- Indexed organism evidence
- REPORTED · SAMPLE_REPORTED: homo sapiens
- Indexed assay evidence
- MAPPED_FROM_REPORTED_TEXT · SAMPLE_MAPPED: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
- Source
- GEO
Original indexed metadata
sample_accession: GSM2325600
sample_title: Patient 160 mucosa control sample
source_name: mucosa
characteristics: patient: Con Patient 160; age: 65.3; gender: M; tissue: mucosa; kras mutation: WT; preoperative radiochemotherapy (rct): 5-FU + RT; depth of invasion before rct: 4; lymph node metastasis before rct: 0; metastasis before rct: 0; depth of invasion after rct: 3; lymph node metastasis after rct: 2; metastasis after rct: 0; cancer recurrance after surgery: 0; disease free time (month): 37.02; death due to tumor: 0; survival time (month): 37.02
organism_code: HOMO_SAPIENS
organism_evidence_status: REPORTED
organism_evidence_source: SAMPLE_REPORTED
organism_evidence_text: homo sapiens
recovery_version: genotype-organism-overlay-v1
recovery_original_snapshot_hash: 6a699f5bab1144f9562bfbd3a264d20460b6b20c63af5cd6530e3e1deaa47fa9
recovery_receipt_sha256: 7e72c8be5c29791ad3f7c71d24524062fc081f3ad99d98b28ae711ce7e1898cd
recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
recovery_source_url: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE87nnn/GSE87211/soft/GSE87211_family.soft.gz
recovery_acquired_at: 2026-09-08T00:59:13Z
assay_evidence_source: SAMPLE_MAPPED
assay_evidence_status: MAPPED_FROM_REPORTED_TEXT
assay_evidence_text: Cy3 intensities were detected by one-color scanning using an Agilent DNA microarray scanner (G2505B) at 5 micron resolution. Scanned image files were visually inspected for artifacts and then analyzed using the Agilent feature extraction software (Agilent Technologies, Santa Clara, CA, USA).
assay_recovery_version: sample-scan-protocol-recovery-v1
assay_recovery_source_sha256: 073cb0e929bd286f60471645d7dd2f79d31f8d0ccca857449631a5c067755f83
assay_recovery_source_field: !Sample_scan_protocol